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Considerable advances in the field of stroke medicine have led to declining trends in 
stroke incidence, disability, and mortality in the Western world. Despite this, the 
absolute number of people affected by stroke has increased. The majority of stroke 
patients in Norway are 75 years or older. With increasing numbers of stroke survivors 
and an aging population, stroke represents a major challenge to healthcare systems 
and public health. Complications and readmissions are frequent after stroke and lead 
to increased morbidity, mortality and health care costs. Readmission is also 
considered a quality-metric for health care services. Studies on which subgroups of 
Norwegian stroke patients that are at highest risk of readmission have not been 
performed in Norway. Further knowledge on the causes of readmission and which 
subgroups of stroke patients that are at highest risk for readmission is important, as it 
may help avoid preventable readmissions after stroke.   
 
Methods and materials 
The thesis is based on studies I-IV, in which data from the Norwegian Stroke 
Research Registry (NORSTROKE) have been used. For the present studies, all 1874 
surviving patients admitted with ischemic stroke or transient ischemic attack (TIA) to 
the stroke unit at Haukeland University Hospital between July 2007 and December 
2013 have been followed by review of medical records for identification of 
unplanned readmissions up to five years after discharge from the stroke unit. Stroke 
etiology was classified according to the TOAST criteria as large-artery 
atherosclerosis (LAA), cardioembolism (CE), small vessel occlusion (SVO), stroke of 
other determined etiology (SOE), or stroke of undetermined etiology (SUE). Patients 
with residency outside the catchment area of Haukeland University Hospital were 




Thirty-day readmission (Study I): The 30-day readmission rate among 1874 
ischemic stroke and TIA patients was 10.7%. The most frequent cause of readmission 
was a stroke-related event, followed by infection, recurrent stroke/ TIA, and cardiac 
disease. Factors that independently increased the risk of 30-day readmission were 
increasing age, peripheral artery disease, enteral feeding, and LAA stroke subtype. 
The risks of all-cause readmission, recurrent stroke, and stroke-related events were 
increased in patients with LAA or SOE subtype, whereas the risk of cardiac disease 
was increased in patients with CE subtype. Thirty-day readmission increased the risk 
of one-year mortality. 
Readmission within 90 days versus day 91-365 (Study II): Of 1175 ischemic 
stroke patients, the first unplanned readmission occurred within 90 days in 18.8% and 
between day 91 and 365 in 24.5%. Infections, recurrent stroke, cardiac disease, and 
stroke-related events were the most common causes of readmission during both 
periods. Increasing age, poorer functional outcome, LAA subtype, atrial fibrillation, 
and an increased risk factor burden were associated with 90-day readmission, 
whereas increasing age and prior myocardial infarction were associated with 
readmission between day 91 and 365. Patients readmitted within 90 days had a shorter 
length of stay during the index admission, a poorer physical function and higher 
frequencies of LAA subtype, atrial fibrillation, and complications with infections during 
the index admission compared to patients readmitted between day 91 and 365. 
Readmission within one year versus the second and fifth year (Study III): Of the 
1453 ischemic stroke and TIA patients followed for five years, 39% were readmitted 
within one year, whereas 53% of the patients that survived for one year without any 
unplanned readmissions were readmitted within five years. Peripheral artery disease was 
associated with readmission within one year, whereas atrial fibrillation was associated 
with readmission between the second and fifth year. Increasing age, poorer functional 
outcome, coronary artery disease, and hypertension were associated with readmission 
during both periods. Patients readmitted within one year were older, had more severe 
strokes, a poorer functional outcome, and more complications during the index 
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admission than patients readmitted between the second and fifth year, but they did not 
differ in the occurrence of cardiovascular comorbidity or prescribed medication at 
discharge or at the time of the first readmission.  
Readmission and death within five years (Study IV): Among 1453 ischemic stroke 
and TIA patients, the five-year incidences of readmission and mortality were 72.6% and 
34.5%, respectively. Both varied significantly between stroke subtypes, with the highest 
incidences in patients with CE or LAA subtype, and the lowest incidences in patients 
with SVO or SOE subtype. After adjusting for age, sex, mRS score, premorbid care-
status, and the risk factor burden, CE subtype had a 25% higher risk of all-cause 
readmission and a 34% higher risk of death compared to other subtypes, whereas SVO 
subtype had a 21% lower risk of all-cause readmission and a 48% lower risk of death. 
Within five years, 30% had been readmitted due to an infection, 20% due to cardiac 
disease, 15% due to a stroke-related event, 14% due to recurrent stroke, and 12% due to 
a fracture. The incidence of readmission due to infection, cardiac disease, and 
fractures varied significantly among stroke subtypes, with the highest incidences of 
all observed in patients with CE subtype. There was no difference in the incidence of 
five-year recurrent stroke or stroke-related events among stroke subtypes.  
 
Conclusions 
The vast majority of ischemic stroke and TIA patients were readmitted within five 
years after discharge from our stroke unit, with more than one-fourth presenting 
during the first three months. Infections, stroke-related events, and cardiovascular 
events including recurrent stroke were the main contributors to readmission. Age, 
poor functional outcome and atherosclerosis in other territories than the 
cerebrovascular one, were important predictors of readmission. Our results also 
demonstrate that the incidence and causes of readmission vary by ischemic stroke 
subtype, and that readmission contributes to higher mortality in stroke patients. 
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The other organs exist to keep the brain functioning normally. Any change in the 
brain’s function and activity profoundly affects living. No medical task exists that is 
more complex, more multifaceted, more important, and potentially more rewarding 
than caring for a stroke patient. 
 Louis R. Caplan. 
 
What defines us as humans and individuals, such as personality, emotions, 
intelligence and sense of humor, are all functions of our brains. Therefore, a stroke 
can be a personal tragedy, striking suddenly and without warning, causing temporary 
or permanent damage which can change us as humans and make us dependent on 
others, or even lead to death. 
The traditional perception of stroke as a geriatric disease, resulting in severe 
disability or death has changed during the last three decades. Due to significant 
advances in the field of diagnostics, stroke medicine and communication, stroke is 
now considered as an event that may occur at any age, and further as a preventable 
and treatable disease with a survival rate higher than ever before. As a result, an 
increasing number of people are living with stroke sequela, and stroke is now the 
third leading cause of long-term disability in the world.1 
A stroke can cause a ripple effect leading to other health problems. Neurological and 
medical complications, deterioration of established diseases, and development of new 
diseases occur both in the acute and chronic phase after stroke as a result of 
neurological impairments, reduced mobility, existing comorbidity, and side-effects 
from medical treatment.2 These complications are important contributors to post-
stroke morbidity and mortality, and they may cause prolonged hospitalizations and 
hospital readmissions.3, 4 Stroke is regarded as one of the most common diseases 
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causing hospital readmissions.4 Readmissions impose a great burden for stroke 
patients and their families and require a substantial amount of health care resources 
for a system already under high pressure on human and economic resources.  
Even though stroke can occur at any age, it is mostly a disease of the elderly.5 The 
life-expectancy in Norway has been steadily increasing, and in 2017, Norwegian 
women and men were expected to live 84 years and 81 years, respectively.6 As a 
result of an aging population with a high life-expectancy and declining post-stroke 
mortality, the number of stroke survivors in Norway will increase. Therefore, the 
number of readmitted stroke patients will presumably increase, challenging the public 














Ischemic stroke and TIA 
Definition 
In 1976, the WHO defined a stroke as “rapidly developing clinical signs of focal (at 
times global) disturbance of cerebral function lasting more than 24 hours or leading 
to death with no apparent cause other than a vascular origin”.7 Advances in 
neuroimaging, neuropathology and basic science led to an updated definition of 
stroke proposed by the Stroke Council of the American Heart Association 
(AHA)/American Stroke Association (ASA) in 2013, including definitions of ten 
conditions which should all be termed stroke.8 Table 1 shows the definition of 
ischemic stroke proposed by the AHA/ASA. 
For the present thesis, ischemic stroke was defined according to the Baltimore-
Washington Cooperative Young Stroke Study Criteria as an episode of neurologic 
deficit lasting ≥24 hours with ischemic lesions on computed tomography (CT) or 
magnetic resonance imaging (MRI), or a clinical transient ischemic attack (TIA) 
where CT or MRI showed infarctions related to the clinical findings.9 This definition 































































If the neurological deficits caused by cerebral ischemia resolves without any 
objective evidence of brain tissue injury, the episode is called a TIA. TIA was 
previously defined as a sudden focal cerebral dysfunction assumed to be of vascular 
origin lasting <24 hours. With emerging imaging advances, studies revealed that 30% 
to 50% of patients with TIA according to the old definition had an acute lesion 
present on diffusion-weighted imaging (DWI).10 A new definition for TIA was 
therefore proposed by the AHA/ASA in 2009 (Table 1).10 The definition of TIA in 
the current thesis is a transient focal cerebral dysfunction lasting <24 hours with no 




In 2013, the worldwide incidence and prevalence of stroke were 10.3 million and 
25.7 million, respectively.1 Stroke was the third most common cause of disability, 
and the second most common cause of death after ischemic heart disease, accounting 
for almost 12% of all global deaths.1, 11 The lifetime risk of stroke after the age of 25 
years is 25%.12  During the past four decades, the stroke incidence has decreased by 
42% in high-income countries but increased more than 100% in low to middle-
income countries.13 Despite the globally declining trends in stroke incidence, 
prevalence, disability, and mortality, the absolute numbers of people affected by 
stroke and people living with disabilities because of stroke, have increased.14 The 
incidence of stroke in Norway has declined from 15000 in the 1990s to 12000 in 
2016.5, 15 Still, cerebrovascular disease is the third most frequent cause of death and 
the fourth most frequent cause of premature death, and a common cause of disability 
among the elderly.16, 17  
Ischemic stroke represents the most common type of stroke and accounts for 71% of 
all stroke survivors and 67% of new strokes.1 In high-income countries, the incidence 
of ischemic stroke has declined by 13% from 1990 to 2010.18 Approximately 51% of 
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all stroke deaths are caused by ischemic stroke. Mortality from ischemic stroke has 
been reduced by 37% from 1990 to 2010.18 TIA was previously considered a benign 
condition compared to ischemic stroke.10 However, TIAs have the same underlying 
mechanism as ischemic strokes, but due to rapid and spontaneous recanalization or 
sufficient collaterals that ensure tissue perfusion, the neurological deficits are 
reversed, and no permanent detectable brain injury occurs. Patients presenting with 
TIA carry a substantial risk of imminent ischemic stroke as up to 15% is reported to 
suffer a stroke within 90 days, with approximately half occurring within the first 48 
hours.10 Incidence rates of TIA range from 0.37 to 1.1 per 1000 annually, but precise 
estimates are difficult to determine because of varying definitions and criteria.10 The 
true incidence of TIA is likely to be greater, as some TIAs may erroneously be 
attributed to other etiologies like migraine, anxiety, presyncope, and seizures, and 
many patients who experience neurological symptoms quickly passing by, and 
consistent with a TIA, do not feel a need to seek medical attention.19 
In 2010, the economic costs of stroke in Europe were estimated to € 64 billion. The 
average costs of an incident stroke were € 21 000, and the costs of a prevalent stroke 
were € 5368.20 The estimations were based on the combined costs of treatment, 
rehabilitation, disability, subsequent nursing and absence from work. The average 
life-time costs of an incident stroke in Norway in 2007 were estimated to 600 000 
NOK with the highest costs during the first year, and the total yearly costs related to 
stroke-care were estimated to 7-8 billion NOK.21 Lower age, more comorbidity, and 
increasing stroke severity and disability are the factors that have the highest impact 







Ischemic stroke and TIA mechanisms 
Ischemic stroke and TIA may be caused by thrombosis, embolism, or hypoperfusion. 
Thrombosis refers to obstruction of blood flow due to a localized occlusive process 
within an artery, reducing the blood flow distally, or giving rise to an embolus that 
occludes a more distant vessel. Embolism refers to obstruction of blood flow caused 
by a thrombus formed elsewhere within the vascular system, either in the heart, the 
aortic arch, the pre-cerebral or intracerebral arteries. Embolism may also occur as a 
paradoxical event by a thrombus from veins, passing by a right-to-left shunt to the 
arteries. Hypoperfusion refers to decreased blood flow or perfusion in a region of the 
brain caused by conditions disturbing cerebral perfusion, such as high-grade stenosis 
in pre-or intracerebral arteries or systemic hypoperfusion, concomitantly with 
insufficient collaterals.23 This usually causes infarctions in the border zone vascular 
areas termed watershed infarction.  
The underlying cause of the ischemic event influences both short-term and long-term 
prognosis and has important implications regarding secondary prevention. For this 
reason, several systems with different criteria have been developed for classification 
of ischemic stroke etiology. The most internationally used causative etiological 
classification in research to date is the Trial of Org 10172 in Acute Stroke Treatment 
(TOAST) classification. The criteria are based on clinical features and result from 
brain imaging, duplex imaging of extracranial arteries, arteriography, cardiac tests 
and imaging and laboratory assessment for prothrombotic states.24 The TOAST 
classification classifies ischemic stroke and TIA in five categories based on the most 
likely cause: large-artery atherosclerosis, cardioembolism, small vessel occlusion, 
other determined etiology, and undetermined etiology. Improved diagnostic tools and 
high percentages of undetermined etiology according to the TOAST classification 
have led to modifications such as the SSS-TOAST (Stop Stroke Study) and CCS 
(Causative Classification System), and development of other classification systems 
such as the ASCO (Atherosclerosis, Small-vessel disease, Cardiac source, Other 
cause) and CISS (Chinese Ischemic Stroke Subclassification).25 The overall 
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agreement between the classification systems are moderate, making the comparability 
and interpretation across studies difficult.26, 27 
Large-artery atherosclerosis (LAA). Atherosclerosis is a multifactorial, slowly 
progressing, systemic and chronic inflammatory disease that can develop in large and 
small arteries. Atherosclerosis may affect multiple organs and lead to cardiovascular 
disease, including cerebrovascular disease. Sites predisposing for development of 
atherosclerosis are branching arterial sites and vessel curvatures due to alterations in 
the blood flow, causing increased turbulence and decreased shear stress.28 For the 
arteries supplying the brain, atherosclerosis mainly affects larger pre-cerebral and 
cerebral arteries that may result in artery-to-artery embolism, thrombosis, or 
hypoperfusion.29 The TOAST classification requires either a >50% stenosis or 
occlusion of a major brain artery or branch cortical artery on vascular imaging for 
classifying a stroke as LAA, and does not take into account the importance of smaller 
unstable plaques.24 The frequency of stroke due to LAA varies from 9% to 32% in 
different studies depending on the study population and classification used,30-36 with 
the highest share in middle-aged stroke patients.32, 37 
Cardioembolism (CE). Embolism from the heart to the brain can result from nearly 
all heart diseases due to stagnation of blood and formation of cardiac thrombosis, and 
from venous embolism crossing onto the arterial site in case of defects in the heart 
septum. The most frequent cause of CE with increasing age is atrial fibrillation. 
Individuals with AF have a 3-to 5-fold increased risk of stroke.38 Other cardiac 
conditions associated with ischemic stroke and TIA are heart failure, myocardial 
infarction, prosthetic heart valves, endocarditis, patent foramen ovale, and rarer 
causes like myxoma, mitral calcification, and papillary fibroelastoma.39 CE stroke 
represents 9% to 33% of all ischemic strokes and is frequent at all ages, but increases 
with age.30-36 
Small vessel occlusion (SVO). Small vessel disease, also called microangiopathy, 
refers to structural changes of the small perforating cerebral arteries and arterioles 
termed lipohyalinosis, characterized by a thickened and stiff vessel wall with the 
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replacement of smooth muscle cells by foam cells and collagen, causing a narrowed 
vessel lumen and in some cases occlusion.40 Imaging features of small vessel disease 
are small, deep-seated infarcts 20 mm primary in the white matter, basal ganglia, 
capsula interna, thalamus or brainstem called lacunar infarctions, deep-seated fluid-
containing cavities 15 mm representing old infarctions called lacunes, primary 
intracerebral hemorrhages, white matter hyperintensities, microbleeds, visible 
perivascular spaces and brain atrophy.40 SVO may also gradually cause cognitive and 
physical disability, leading to depression and dementia.40 The frequency of ischemic 
stroke due to SVO varies from 7% to 25%,30-36 and is more common in middle-aged 
and older stroke patients.32, 37 
Stroke of other determined etiology (SOE). Ischemic stroke and TIA can be caused by 
spontaneous or traumatic arterial dissection, in which a tear in the intima of the 
arterial wall causes an intramural hematoma that may obstruct the arterial lumen or 
cause intraluminal thrombosis and distal embolization.41 Other defined causes are 
hematologic abnormalities due to high blood cell counts or abnormal blood cells, 
deficiencies of natural anticoagulants, pro-thrombotic conditions in pregnancy, and 
malignancy.42-44 Migraine is associated with ischemic stroke, especially in women 
with migraine with aura.45 Non-atherosclerotic vasculopathies such as fibromuscular 
dysplasia and infectious or non-infectious vasculitis, and a number of hereditary 
metabolic disorders are other causes among SOE.46 SOE is more common in stroke 
patients <50 years of age.37 In the TOAST classification, these are all classified as 
SOE.24 
Stroke of undetermined etiology (SUE). In some cases, the etiology of the stroke is 
not found, either despite adequate diagnostic evaluation (cryptogenic stroke), or 
because not all necessary investigations are performed. In others, there may be two or 
more potential causes of the stroke, and it cannot be determined which of them was 
causative.24, 47 Stroke of undetermined etiology refers to all three cases, where the 
cause of the ischemic stroke or TIA cannot be determined with any degree of 
confidence and does not meet the criteria for an established subtype. 24  
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Modifiable stroke risk factors 
Risk factors of stroke can be stratified into non-modifiable and modifiable risk 
factors. Factors related to natural or hereditary processes such as age, sex, ethnicity, 
family history, and genetics have impact on stroke prevalence and ischemic stroke 
subtypes, but they cannot be modified.32, 37, 48, 49 Modifiable risk factors relate to 
lifestyle choices and environment and are factors that can be prevented or modified 
by the use of medical treatment and lifestyle changes. More than 90% of all strokes 
and 90% of the stroke burden are attributable to modifiable risk factors.50 These risk 
factors may potentiate each other if coexistent,49 and are not exclusive to stroke, but 
also to other cardiovascular disease, such as coronary artery disease and peripheral 
artery disease, or to cancer. However, some modifiable risk factors may also have 
genetic components, such as known for some forms of hypertension, diabetes 
mellitus, and hypercholesterolemia. 
Hypertension. Hypertension is the most important modifiable risk factor for ischemic 
and hemorrhagic stroke, and the risk increases with increasing blood pressure, even 
including the non-hypertensive range.49 The prevalence of hypertension among 
Norwegian stroke patients was 57% in 2017.51 Hypertension is also a major risk 
factor for other cardiovascular diseases, including coronary heart disease, heart 
failure, peripheral artery disease, and kidney failure.52 
Diabetes mellitus. Diabetes mellitus is a major risk factor for cardiovascular diseases, 
especially in patients younger than 65 years of age.49 It has been suggested that the 
presence of diabetes mellitus more often results in irreversible ischemic damage, 
more severe stroke, slower recovery, and higher mortality.53, 54 The prevalence of 
diabetes mellitus in Norwegian stroke patients was 17% in 2017.51 
Coronary and peripheral artery disease. Symptomatic and asymptomatic 
atherosclerosis in the coronary and peripheral arteries is a marker of systemic 
atherosclerosis, and a risk factor for extracranial artery disease and stroke.55, 56 Stroke 
risk factors are shared with atherosclerotic disease in other territories, and the 
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presence of coronary or peripheral artery disease is associated with recurrent arterial 
events and a worse long-term outcome after stroke.57 
Dyslipidemia. Dyslipidemia, especially high cholesterol, is a risk factor for 
cardiovascular disease.49 The causal association with stroke is less clear and limited 
to specific stroke subtypes, particularly LAA and SVO.32, 58 The prevalence of 
hypercholesterolemia in Norwegian stroke patients was 35% in 2017.51  
Smoking. Cigarette smoking is the attributable cause in up to 25% of all strokes.59 
The relationship between cigarette smoking and stroke is dose-dependent, with 
increasing risk with the number of cigarettes smoked per day. Smoking is harmful to 
nearly every organ in the body and attributes to many diseases including 
cardiovascular disease, cancer, pneumonia, and chronic obstructive pulmonary 
disease.60  
Other lifestyle factors. Both irregular and chronic heavy alcohol consumption 
increases the risk of ischemic stroke, as well as diseases of the liver, pancreas, 
gastrointestinal tract, the heart, cancer, and osteoporosis.49, 61 Other lifestyle factors 
which may increase the risk of stroke include physical inactivity, obesity, diet, and 
illicit drug use that may lead to hypertension and diabetes mellitus.49  
Inflammation. Results from several studies have demonstrated an associated between 
inflammatory conditions and ischemic stroke.62, 63 Important features of this complex 
process is the anti-inflammatory response with activation of the coagulation.64 
Furthermore, chronic infections and inflammation can trigger and accelerate 
atherosclerosis.62 Between 10 and 40% of ischemic stroke patients have had an acute 
infection during the week preceding stroke, most commonly in the respiratory tract.63 
Furthermore, some evidence point to a protective effect of influenza vaccination 





Reduction of stroke incidence, disability, recurrence, and mortality involves five 
aspects; 1) primary prevention, 2) acute treatment with thrombolysis and 
thrombectomy, 3) hospitalization with clinical workup, treatment, and prevention of 
complications, 4) secondary prevention, and 5) rehabilitation including 
physiotherapy, occupational therapy, and speech and language therapy. As most 
recurrent strokes are caused by the same mechanism as the initial stroke, 
identification of the stroke mechanism is of utmost importance in secondary stroke 
prevention.68 However, some patients may also have other underlying conditions that 
can lead to a subsequent stroke, and therefore, detection and treatment of comorbidity 
is important in order to reduce the risk of recurrent stroke. Secondary prevention has 
additional effects on reducing the development of other vascular diseases, 
cardiovascular mortality, and all-cause mortality. 
Treating modifiable stroke risk factors impacts both primary and secondary 
prevention. Lifestyle modifications including smoking cessation, weight reduction in 
obese patients, limited alcohol consumption, salt restriction, adherence to a 
Mediterranean diet, and physical activity are important to reduce the risk of recurrent 
stroke, cardiovascular complications, and mortality.69 These measures are also 
reasonable parts of antihypertensive and lipid-lowering therapy. All stroke patients 
with either known or newfound hypertension should be treated with antihypertensive 
medication.69 Use of antihypertensive treatment and reduction in blood pressure 
reduces the risk of recurrent stroke, myocardial infarction, and cardiovascular death.70 
Lipid-lowering therapy should be provided for all patients with known 
hyperlipidemia, coronary artery disease or atherosclerosis in other territories. Lipid-
lowering therapy reduces the risk of recurrent stroke even in the absence of 
cardiovascular comorbidity and hyperlipidemia for all stroke patients, but especially 
for those with IS or TIA assumed to be of atherosclerotic origin.69, 71 Good and 
consistent blood glucose control reduces microvascular complications and 
macrovascular complications in patients with impaired glucose intolerance or 
diabetes mellitus.72  
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Patients with a stroke of atherosclerotic origins such as LAA or SVO should be 
treated with antiplatelet therapy.73 A combination of acetylsalicylic acid and 
dipyridamole is often used if tolerated by the patient, as it is at least as effective as 
monotherapy for secondary stroke prevention.74 Clopidogrel monotherapy is an 
alternative to aspirin or the combination of aspirin and dipyridamole.69 Carotid 
surgery or endovascular stenting are recommended in patients with stenosis ≥70% of 
the proximal carotid artery and ipsilateral cerebral infarction, with a reduction in 
absolute risk of five-year stroke recurrence from 4.6 to 16%.69, 75, 76 Carotid surgery in 
ischemic stroke or TIA patients with a moderate ipsilateral stenosis (50-69%) is 
recommended depending on patients specific factors such as age, sex, and 
comorbidity.69, 76 Early surgical intervention between 48 hours and 14 days after a 
TIA or minor disabling stroke is recommended in selected patients due to a high risk 
of early recurrent stroke.69, 77, 78 For patients with stroke of cardiac origin, 
anticoagulation is superior to platelet inhibitors, with a reduction in the annual stroke 
rate from 12% to 4%,79 but the annual risk of major bleeding is slightly increased 
(1.3% versus 1% in patients treated with platelet inhibitors or placebo).80 The 
duration and intensity of the treatment with anticoagulation depends on the 
underlying cardiac cause of the stroke.69 Treatment of arterial dissection includes 
anticoagulation or antiplatelet therapy for at least three to six months, and 
endovascular treatment with stenting may be considered in patients with recurrent 
events despite medical therapy.69  
Most strokes result from systemic diseases which may additionally affect other 
organs and the patient’s general health. In addition to the secondary prevention of 
recurrent stroke and cardiovascular events, detection of swallowing problems, 
maintenance of adequate nutrition, cognitive and physical rehabilitation, and 
prevention and care of post-stroke complications are key factors in caring for a stroke 
patient. Admission of stroke patients to dedicated stroke units and centers improves 
stroke outcomes by limiting stroke morbidity, reducing the need for institutionalized 
care, improving quality of life after stroke, and reducing short-term and long-term 
mortality.81-83  
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Outcome and complications 
The most used parameters for determining outcome after stroke are degree of 
dependency and death. Although ischemic stroke mortality has declined over the last 
decades, it remains a major cause of long-term institutionalization and one of the 
leading causes of death worldwide.18 The risk of death is highest within the first 30 
days after stroke onset.84 In the Norwegian National Stroke Registry, the overall in-
hospital mortality rate after stroke was 8.1% in 2017.51 The most important factors 
affecting outcome after stroke are advancing age and stroke severity, including 
neurologic impairment and size and location of the infarction.85-88 Comorbidities like 
coronary artery disease, heart failure, diabetes mellitus, cancer, and renal dysfunction 
also increase the risk of poor outcome.86, 88, 89  
Stroke outcome is also highly related to complications. Between one-fourth and 
three-fourths of all stroke patients experience either neurological or medical 
complications.90, 91 Neurological complications include brain edema, hemorrhagic 
transformation, recurrent stroke, neurological deterioration, seizures, epilepsy, and 
delirium, whereas medical complications include a wide range of complications of 
the heart, lungs, gastrointestinal tract, and genitouritrary system, and other conditions 
like venous thromboembolism, fractures, decubitus ulcers and psychological 
conditions. In general, medical complications are more frequent than neurological 
ones, but neurological complications occur earlier and usually within 48 to 72 hours 
after stroke onset, whereas medical complications usually develops within weeks 
after stroke onset.2, 92, 93 However, both may occur up to several years after the initial 
stroke, and adversely affects the post-stroke outcome with increased physical and 
cognitive disability and higher short-term and long-term mortality.2, 92-94 Post-stroke 
complications often lead to prolonged hospitalizations, delayed rehabilitation, 




Readmission after ischemic stroke and TIA 
Hospital readmission is defined as a new admission to the same or another hospital 
within a specified time interval after discharge. Readmissions may reflect different 
problems or a combination of problems and are often used as an outcome measure in 
addition to disability and death. Readmissions may result from poor quality of care 
during initial admission or afterward, caused by incomplete treatment, unresolved 
problems, poor care of underlying problems, inadequate communication and 
misunderstandings, and poor coordination of services such as discharge planning or 
access to health care. For this reason, readmissions are frequently used as a quality-
indicator for health care services. Readmissions may also reflect an old and 
chronically ill population with substantial disability and morbidity and a high risk of 
deterioration of chronic conditions and a higher occurrence of complications. 
Individuals with chronic diseases, usually increasing with increasing age, have 
different clinical needs than persons without chronic diseases and a more rapid 
decline in health status and a greater chance of disability and repeated 
hospitalizations.97  
Hospital readmissions impose a great burden on the health care system that demands 
a significant share of the available health care resources concerning personnel, 
hospital beds, and health care costs. A study from the US estimated that readmissions 
generated approximately one-fifth of all Medicare costs between 2003 and 2004.98 
Readmission rates have been steadily increasing, and in 2016, early readmissions 
accounted for about 9% of all day-care and bed days in Norwegian hospitals.99 Stroke 
patients are one of five patients groups which show the highest numbers of 
readmissions in Norway.4 Studies have shown that the healthcare payments related to 
stroke patients increase with each readmission, and a considerable share of the first-
year healthcare payments of stroke patients are spent on readmissions.3, 100 There are 
no precise estimates of the costs of readmissions after stroke in Norway, but a study 
from Scotland estimated the mean costs per readmission after an ischemic stroke to 
£4,487 in 2004.101  
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New acute illnesses in addition to the stroke cause more morbidity and interfere with 
post-stroke recovery, which may further lead to a reduced cognitive and physical 
function and higher mortality. The likelihood for surviving for one year after stroke 
declines with increasing numbers of early readmissions, from 83% in patients with no 
readmission to 67% in patients with one readmission, to 55% in patients with 2 or 
more readmissions.3 The early period following discharge represents an especially 
vulnerable period for readmission, as readmission within the first 90 days represents 
more than half of all readmission happening within one year after discharge.102-105 
Within five years, less than 15% of all stroke patients are alive and have never been 
readmitted, and after ten years, the number of patients alive and never readmitted 
declines to 6.6%.105, 106 
 
 
Links between stroke and other diseases 
Infections. Infections complicate up to 30% of all strokes in the acute phase and have 
a negative impact on the post-stroke outcome with higher rates of dependency and 
mortality.107 Three interacting mechanisms likely contributes to development of post-
stroke infections; (1) neurological deficits such as dysphagia, impaired cough reflex, 
hypoventilation, bladder problems, and reduced mobility, (2) procedures like 
intubation, nasogastric tube feeding, and urinary catheterization, and (3), stroke-
induced immunosuppression, characterized by autonomic dysregulation causing 
alterations in immune cell function and number. The suppression of the immune 
system minimizes excessive inflammation in the injured brain but consequently 
increases the susceptibility for infections.108 A fourth possible cause is infections 
before the stroke which manifests or worsens after stroke onset. Infections have been 
shown to precede and trigger stroke in many studies, and infection, especially in the 
week before stroke onset, is an independent risk factor for ischemic stroke.63 As 
swallowing dysfunction and bladder problems frequently follow stroke, the most 
frequent post-stroke infections are pneumonia and urinary tract infection (UTI). 
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Stroke patients who develop pneumonia have a significantly poorer long-term 
outcome and higher mortality than patients without pneumonia.109 Stroke-associated 
pneumonia is usually caused by aspiration related to swallowing impairment or a 
decreased level of consciousness.2, 90 Contrary to pneumonia, most UTIs after stroke 
are uncomplicated and does not affect stroke outcome when other factors like stroke 
severity and premorbid status are taken into account.90, 110  
Recurrent stroke. Ischemic stroke and TIA patients are at considerable risk of 
suffering further strokes compared to the general population, and recurrent strokes are 
more likely to be disabling or deadly.111-113 The risk of recurrent stroke is especially 
high during the first weeks after the onset of stroke symptoms and declines over 
time.114 The combined annual risk of recurrent stroke after IS or TIA was found to be 
4.3% in a meta-analysis of 34 studies.114 Treatment adherence and occurrence of 
cardiovascular risk factors have profound impact on the risk of recurrent stroke. 
Major risk factors for recurrent stroke include increasing age, hypertension, atrial 
fibrillation, carotid stenosis, cardiac disease, smoking, and diabetes mellitus.91, 115  
Coronary artery disease. Stroke and coronary artery disease share many risk factors 
and pathogenic processes. Accumulating evidence suggests that even in the absence 
of known risk factors and cardiac disease, suffering a stroke is a risk factor for having 
underlying coronary artery disease.116 The annual risk of myocardial infarction in a 
recent meta-analysis was 1.67%, and the risk increased more than a 3-fold in patients 
with a history of coronary artery disease compared to patients with no history of 
coronary artery disease.114 Risk factors for myocardial infarction after stroke include 
male sex, hypertension, and a history of coronary artery disease or peripheral artery 
disease.114 Atherosclerosis is the primary cause of coronary artery disease, and 
patients with LAA as cause of the stroke have generally a higher occurrence rate of 
coronary artery disease.117, 118 
Venous thromboembolism. Venous thromboembolism (VTE), including deep vein 
thrombosis (DVT) and pulmonary embolism, is a major concern after stroke.90 Severe 
stroke, immobilization, limb paralysis, high age, dehydration, and acute medical 
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conditions predispose patients to DVT development, which may result in persistent 
limb pain, swelling and venous ulceration (post-thrombotic syndrome) or pulmonary 
embolism.90, 119 Clinically overt pulmonary embolism occurs in 1% during the first 
two weeks after stroke onset.120 The risk of VTE after stroke is highly increased 
during the first three months after stroke and decreases rapidly after that.90 In the 
Tromsø study, the risk of VTE was considerably increased during the first three 
months after an ischemic stroke, with a 20-fold increased risk the first 30 days and an 
11-fold increased risk in the second and third month. After three months, the risk was 
almost the same as for the general population.119 
Cardiac disease. Shared risk factors between stroke and cardiac conditions and 
underlying diseases of the heart causing the stroke, make cardiac diseases common in 
stroke patients. The brain damage caused by the stroke can also induce autonomic 
dysfunction, which together with physiological stress makes cardiac dysfunction a 
frequent accompaniment of stroke in the acute phase.121 It usually manifests as a mild 
and reversible dysfunction which resolves in a few weeks, but it can also cause life-
threatening conditions like myocardial infarction, ventricular arrhythmias, heart 
failure, and cardiac arrest, and lead to long-term cardiac damage.121 Arrhythmias 
frequently follow stroke or can be the cause of stroke, as in the case of atrial 
fibrillation. The occurrence of new arrhythmias are particularly high the first few 
days after stroke, and up to 67% of all ischemic stroke patients have ischemic or 
arrhythmic abnormalities on ECG.90, 121 Heart failure is common in stroke patients, 
both as a concurrent condition because of an aging population with structural or 
functional damage to the heart, or as a complication of stroke due to new-onset 
myocardial infarction, acute hypertension, or iatrogenic complications such as 
changes in medications or fluid overload.90, 121 Concurrent stroke and heart failure 
have an adverse effect on each other, with stroke increasing the severity and duration 
of heart failure, and heart failure leading to increased stroke severity and post-stroke 
complications.122    
Neurological deterioration. Neurological deterioration after stroke is a frequent and 
feared complication in acute stroke patients that usually occurs within the first week 
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after onset.91, 123 Signs include progression of focal neurological symptoms or a 
decrease in the level of consciousness, and can be caused by brain edema, 
hemorrhagic transformation, a progression of brain ischemia, propagation of 
thrombus, metabolic disturbances, hypotension, seizures, delirium or recurrent 
stroke.91 Neurological deterioration is less common in the sub-acute and chronic 
phase after stroke but may occur in relation to seizures, recurrent stroke, metabolic 
disturbances, or infections.123  
Seizures and epilepsy. Stroke is the most common cause of acute symptomatic 
seizures and epilepsy in adults over 34 years of age.124 Post-stroke seizures are 
divided into early seizures occurring within one to two weeks, and late seizures 
manifesting later than two weeks.91 Early seizures may be related to cellular 
biochemical dysfunction leading to electrically irritable tissue and occur in 2% to 
23% of all stroke patients.125 Late seizures are thought to be caused by permanent 
lesions and occur in 3% to 67%.125 More than 50% of patients with late-onset seizures 
have recurrent seizures, and they have a higher likelihood of developing chronic 
epilepsy than patients with early-onset seizures, but the risk of developing epilepsy is 
still higher after an early-onset seizure compared to stroke patients without early-
onset seizures.91, 125 Cortical lesions and increasing stroke severity are the most 
consistent risk factors for post-stroke seizures and epilepsy.125-128 Young stroke 
patients also have a higher risk of post-stroke epilepsy, but this could be caused by 
survival rather than increased susceptibility to epileptogenesis.126, 128 
Fractures. The risk of fractures increases considerably after a stroke.129, 130 Falls may 
occur due to balance difficulties, neglect, sensory loss, visual problems, cognitive or 
motor impairment, seizures, or use of sedative medication.90, 131 The incidence of 
post-stroke falls varies considerably among studies, ranging from 23% to 34% at 3 to 
4 months, and 40% to 70% within one year.132 Bone-density changes with increased 
bone resorption secondary to bed rest, immobility and paretic limbs in combination 
with age-associated osteoporosis in older stroke patients increase the risk of 
fractures.133 Compared to healthy individuals of comparable age, stroke patients with 
paretic lower or upper limbs have up to a 10-fold and 20-fold higher bone resorption, 
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respectively.134 Most fractures occur on the paretic side secondary to falls, and almost 
half of all fractures involves the hip joint.135, 136 Compared to a non-stroke population, 
the risk of fractures is increased up to a 7-fold during the first year after stroke.129  
Gastrointestinal bleeding. Gastrointestinal (GI) bleeding is the most common source 
of major extracranial bleeding after stroke. Approximately 1.5% to 5% of all strokes 
are complicated by GI bleeding, most often occurring in the upper GI tract.2, 137, 138 GI 
bleeding is associated with recurrent stroke, myocardial infarction, and VTE and has 
a significant impact on post-stroke dependency and mortality.90, 138  
 
 
Risk factors for readmission after ischemic stroke and TIA 
Hospital readmissions have been receiving increased attention as it may be a 
correctable source of excessive spending and poor quality of care. Information on 
reasons why readmissions occur can help prevent avoidable readmission by assisting 
clinicians and health care institutions in identifying high-risk patients and further 
initiate interventions to prevent readmission. Therefore, readmission risk prediction 
models have gained increasing attention. Clinically relevant stratification of 
readmission risk could contribute with information that would trigger interventions 
during hospitalization and in the immediate period after discharge. A systematic 
review from 2011 including studies of readmission after various diseases identified 
26 unique models for predicting the risk of readmission.139 Most of the studies 
included variables of medical comorbidity and prior hospitalizations, but few 
consider parameters related to disease severity, functional outcome and social 
determinants of health.139  
Since stroke is a frequent cause of hospital readmissions, and readmission after stroke 
results in adverse outcomes for patients and generates high health care costs, many 
studies have tried to identify factors that influence the readmission rate among stroke 
patients. There are different aspects of reasons which might lead to readmission that 
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have to be considered in the identification of factors related to readmission after 
stroke (Figure 1). Patient characteristics, such as age, cardiovascular risk factors, and 
comorbidity, may generate a higher risk of readmission by the development of a new 
disease or worsening of co-existing disorders. Stroke specific measures, such as the 
degree of neurological deficits, stroke severity and functional disability may have 
impact on the readmission risk, as these measures are related to post-stroke 
complications and outcome. Measures on clinical process of care, health system and 
health outcomes, such as stroke unit care, duration of the index admission, occurrence 
and treatment of complications during index admission, and discharge planning might 
provide information on the quality of the provided care. It might be an especially 
valuable approach to identify potentially preventable readmissions. A final aspect is 












A systematic review from 2010 identified 16 studies examining the risk of 
readmission after stroke.141 Several risk factors were identified, but there was little 
consistency between the included studies and a considerable heterogeneity in the 
selection of covariates that could be related to readmission. Furthermore, the review 
did not identify any studies that provided a risk-standardized model for prediction of 
readmission risk after stroke.  
As ischemic stroke and TIA are heterogeneous disorders caused by various diseases, 
many of the aspects that should be considered when investigating factors associated 
with readmission after stroke can be influenced by the stroke subtypes. Although 
studies show some varying results in the distribution and frequency of the different 
cardiovascular risk factors, stroke patients with LAA or SVO have the highest 
occurrence of hypertension, hyperlipidemia, diabetes mellitus, and smoking, which is 
likely related to the pathogenesis of these diseases.32, 35, 40, 142, 143 Stroke patients with 
LAA also have the highest prevalence of coronary artery disease, peripheral artery 
disease, and TIA.32, 33 Stroke patients with CE are the oldest among the stroke 
subtypes, and stroke patients with SOE are usually the youngest.32, 142 The most 
severe strokes and subsequently high functional disability is found in stroke patients 
with CE, whereas SVO is associated with milder deficits.144  
The differences in age, cardiovascular risk factor profile, comorbidity, and stroke 
severity between the stroke subtypes results in different risks of new cardiovascular 
events, cardiovascular mortality and overall mortality.32, 144 Specific associations of 
risk factors for readmission could be diluted and underestimated in analysis 
combining all subtypes into one stroke category. Only a minority of studies about 
readmission after stroke have included information on ischemic stroke subtypes. 
Characterization of incidence and causes of readmission after stroke according to 
stroke subtype might provide a more detailed understanding of why stroke patients 
are readmitted and contribute to more effective secondary prevention of not only 
recurrent stroke and vascular events, but also other diseases.  
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Aims of the thesis 
1. To assess the rates and incidence of short-term and long-term unplanned 
hospital readmission after ischemic stroke or TIA.  
 
2. To assess the most frequent causes of short-term and long-term unplanned 
hospital readmission after ischemic stroke or TIA. 
 
3. To assess factors associated with unplanned hospital readmission within 
different periods after ischemic stroke or TIA. 
 
4. To assess similarities and differences in risk factors for patients readmitted 
within different periods after ischemic stroke. 
 
5. To assess the impact of ischemic stroke subtype on the incidence and causes of 
hospital readmission to elucidate the underlying causes of readmission. 
 
6. To assess the impact of thirty-day readmission after ischemic stroke or TIA on 





Material and methods 
Bergen NORSTROKE registry 
Data for all papers in the thesis have been obtained from the NORSTROKE registry, 
and from the medical journals of all included patients after discharge from the stroke 
unit at Haukeland University Hospital. 
NORSTROKE has since 2006 prospectively registered all patients >18 years of age 
admitted with IS, intracerebral hemorrhage or TIA to the stroke unit at the 
Department of Neurology, Haukeland University Hospital. The stroke unit serves a 
well-defined geographical area of approximately 275,000 inhabitants, in addition to 
stroke patients <60 years of age from neighboring regions and all patients eligible for 
endovascular stroke treatment. The study has been approved by the Western Regional 
Ethics Committee and written informed consent is obtained from all patients or their 
legally authorized representatives. 
All patients with suspected stroke were admitted to the hospital either directly or after 
examination in primary health care. Upon admission, patients were examined by a 
residence in neurology and scored by the National Institute of Health Stroke Scale 
(NIHSS) score. Urgent computed tomography (CT) was performed in all patients to 
assess early ischemic changes, hemorrhages, or other apparent causes of the 
symptoms. If the patients presented <6 hours after onset of symptoms, CT 
angiography was performed to assess possible occlusions available for endovascular 
treatment, unless contraindicated.  
Unless contraindicated, all patients routinely underwent magnetic resonance imaging 
(MRI) and magnetic resonance angiography using 1.5 or 3 Tesla Siemens magneton 
(Symphony) on the day after admission. Not all patients with suspected TIA 
underwent MRI during the first years of the NORSTROKE Study due to a limited 
MRI capacity. A neuroradiologist and a stroke neurologist (HN) reviewed all MRI 
scans. Examination of the extracranial arteries was regularly performed by Duplex 
ultrasound within one day of admission by a resident or attending neurologist in the 
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Stroke Unit. Electrocardiography (ECG) was obtained in all patients, and patients 
with suspected cardioembolic etiology underwent echocardiography and Holter 
monitoring. All patients were mobilized early and referred to a professional 
rehabilitation team as appropriate.  
NORSTROKE is conducted by a standardized form which is prospectively filled out 
during treatment and follow-up during stroke admission. NORSTROKE includes data 
on the patient’s age, sex and time of symptom and admission, prior medical history 
and cardiovascular risk factors, clinical findings and vital parameters, results from 
examinations including radiological, neurosonological, cardiological and laboratory 
findings, treatment during admission, complications, medications prior to index 
admission and at discharge, short-term outcome, and discharge date and discharge 
destination. 
Registered prior medical disease and stroke risk factors included hypertension 
(considered present if diagnosed by a physician before stroke onset), diabetes mellitus 
(considered present if glucose lowering diet or medication had been initiated before 
admission or if revealed by a HbA1c > 6.4% during hospital admission), and atrial 
fibrillation (considered present if confirmed by ECG at any time prior to admission or 
during hospital admission). Registration of prior stroke or TIA, myocardial infarction, 
angina pectoris, and peripheral artery disease were based on information from the 
patient, partner or relatives of the patient, or abstracted from the medical journal. 
Smoking habits were categorized as current smoker (at least one cigarette per day), 
previous smoker (cessation of smoking at least one year before stroke onset) and 
never smoker. A variable representing the total number of cardiovascular risk factors 
(0, 1, 2, ≥3) was made and defined as risk factor burden. Risk factor burden included 
hypertension, diabetes mellitus, smoking, angina pectoris, prior myocardial 
infarction, and peripheral artery disease. The risk factor burden has previously been 
associated with an increased risk of recurrent ischemic stroke.145  
Stroke severity was determined by the NIHSS score. The score is a 15-item 
impairment scale ranging from 0 to 42, where a score of 0 is no neurological 
 37 
impairment, and 42 is the most severe impairment. The NIHSS score is reliable and 
valid and the standard stroke impairment scale used in both clinical care and most 
clinical trials.146 However, the score does not capture all stroke-related deficits, such 
as fine motor skills, tempo, and symptoms from areas supplied by the vertebrobasilar 
circulation.147 The NIHSS score was assessed immediately on admission, after one 
hour and subsequently for standardized intervals by a stroke nurse in the stroke unit 
for evaluating improvement, stability or progression. Stroke in progression was 
defined as a worsening of 4 or more points from the admission NIHSS score. Patients 
were finally scored by the NIHSS score on day 7 or at discharge if earlier.  
Short-term outcome was determined by the modified Rankin Scale (mRS) score and 
Barthel Index (BI) score day 7 or on the day of discharge if earlier. The mRS score 
measures function, and an mRS score 0-2 is generally regarded as favorable 
functional outcome while mRS 3-5 is regarded as unfavorable and poor outcome 
because of dependency, and 6 represents death (Appendix).146 The BI measures ten 
basic aspects of self-care and physical dependency. Scores lower than 100 indicate an 
increased disability, a BI >60 corresponds to assisted independence, and a BI <40 
corresponds to severe dependency.148 
Based on findings from clinical examination and radiological, neurosonological, 
cardiological and laboratory assessments, ischemic stroke and TIA etiology was 
categorized by the TOAST classification as large artery atherosclerosis (LAA, 
localized or artery-to-artery embolism), cardioembolism (CE, medium or high risk), 
small vessel occlusion (SVO), stroke of other determined etiology (SOE, arterial 
dissection, hematological abnormalities, miscellaneous causes), and stroke of 
undetermined etiology (SUE, cryptogenic stroke, incomplete evaluation or competing 





Patients admitted between July 2007 and December 2013 to the Stroke Unit at 
Haukeland University Hospital were followed by review of electronic medical 
records. The electronic medical review included medical records from all ten 
hospitals in the region of the Western Norway Regional Health Authorities 
(Haukeland University Hospital, Haraldsplass Deaconess Hospital, Voss Hospital, 
Lærdal hospital, Nordfjord Hospital, Førde Central Hospital, Stord Hospital, Odda 
Hospital, Haugesund Hospital, and Stavanger University Hospital). The region is one 
of four regional health authorities in Norway, and includes approximately 1.1 million 
inhabitants in the counties of Rogaland, Hordaland and Sogn og Fjordane (Figure 2). 
Data on mortality after discharge was also extracted from the medical records, which 
is automatically and continuously updated from the Norwegian National Registry 
(Folkeregisteret). 
Data collected for each readmission included the date of readmission, departments, 
primary diagnosis, secondary diagnoses, blood pressure, working status, current 
smoking, alcohol abuse, discharge date, and discharge destination. Medical treatment 
at first and last readmission and were registered, as well as the date of death. All 
readmissions were registered, but only unplanned (emergency) readmissions were 
included in the studies. Time from discharge to the first unplanned readmission 
represented time to readmission. 
Only patients with residency in the catchment area of Haukeland University Hospital 
(Figure 2) at time of the index admission were registered and included in the papers 
of the thesis. Patients who died or moved outside the region of the Western Norway 
Regional Health Authorities during follow-up before any readmission had occurred 









Paper I studied rates, causes and risk factors for readmission within 30 days after 
discharge in ischemic stroke and TIA patients. Patients admitted between July 2007 
and December 2013 were included in the study, and the final study cohort included 
1874 ischemic stroke and TIA patients. The study also examines the rates, causes, 
and risk of 30-day readmission for each stroke subtype, and the impact of 30-day 
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Paper II studied readmission within one year after discharge in patients admitted 
with ischemic stroke from July 2007 to July 2012. Of 1250 patients, 1175 survived 
the index admission and were included in the study. Due to administrative causes, 
only readmissions to Haukeland were included in this study. Readmitted patients 
were divided into two groups: those who were readmitted within 90 days after 
discharge (defined as early readmission), and those who experienced the first 
readmission from day 91 to 365 after discharge (defined as late readmission). Patients 
that could not be followed for the respective time intervals were excluded. For the 
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Paper III studied readmission within five years in the 1453 ischemic stroke and TIA 
patients that were discharged alive and could be followed for five years after 
discharge from the stroke unit. Readmitted patients were divided into two groups: 
those who were readmitted within one year after discharge, and those who 
experienced the first readmission between years 2-5 after discharge. For the analyses 
on readmission between years 2-5, patients that were readmitted or dead within one 
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Paper IV studied five-year readmission and mortality by ischemic stroke subtype. 
All patients with ischemic stroke or TIA that could be followed for five years after 
discharge from the index admission were included. After exclusion of 92 patients that 
died during the index admission or were discharged to palliative care, the final study 
cohort consisted of 1453 patients. All unplanned readmissions were included, and the 
incidences of all-cause and cause-specific readmission were calculated for each 
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The chi-square test was used for the univariate analyses of categorical variables.  
Student’s t-test and one-way ANOVA were used for the univariate analyses of 
normally distributed continuous variables, whereas Wilcoxon rank-sum test and 
Kruskal-Wallis H-test were used for skewed continuous variables.  
Kaplan Meier estimates were used to determine incidences of all-cause and cause-
specific readmissions and mortality, and the log-rank test was applied for comparison 
of incidence estimates between the stroke subtypes. Kaplan-Meier failure curves were 
made to demonstrate the incidence of all-cause and cause-specific readmission and 
mortality over time. To evaluate for possible bias caused by the competing risk of 
mortality, we compared the Kaplan-Meier incidence estimates of all-cause and cause-
specific five-year readmissions to age-adjusted cumulative incidence estimates from 
survival models that accounted death as a competing risk (Fine-Gray model).149 
Multivariate analyses were performed using logistic regression and Cox regression by 
stepwise backward elimination starting with all statistically significant variables 
(p<0.05) from the univariate analyses. Age, sex, and mRS score have been forced 
into all regression analyses to adjust for potential confounding. Length of stay was 
additionally forced into the regression analysis on 30-day readmission, 90-day 
readmission, and 91-365 day readmission, and the risk factor burden and premorbid 





Summary of papers 
 
Paper I: 30-day hospital readmission 
Of the 1874 patients with ischemic stroke or TIA that were discharged alive, 200 
(10.7%) were readmitted within 30 days. There were significant differences in 30-day 
readmission among the stroke subtypes (LAA: 17.2%, CE: 12.4%, SVO: 5.9%, SOE: 
18.8%, SUE: 8.3%). The overall most frequent causes of readmissions were a stroke-
related event, infection, recurrent stroke/ TIA, and cardiac disease, but the rates 
varied significantly among the stroke subtypes. Factors that significantly increased 
the risk of 30-day readmission were increasing age (HR=1.02, 95% CI=1.01-1.03), 
peripheral arterial disease (HR=1.58, 1.01-2.47), enteral feeding (HR=1.86, 1.11-
3.11) and LAA subtype (HR=1.74, 1.20-2.51). After adjusting for age, sex, functional 
outcome, length of stay and the risk factor burden, patients with LAA or SOE subtype 
had significantly higher risks of readmission for any cause (HR=1.76, 1.22-2.53 and 
HR=2.81, 1.11-7.10, respectively), recurrent stroke or TIA (HR = 3.31, 1.55-7.07 and 
HR=6.00, 1.26-28.57, respectively) and stroke-related events (HR=2.98, 1.55-5.74 
and HR=4.27, 1.19-15.35). Thirty-day readmission increased the risk of death within 
one year (HR=2.57, 1.75-3.78). 
 
Paper II: Hospital readmission within 90 days versus day 91-365 
Of the 1175 ischemic stroke patients discharged alive, 18.8% were readmitted within 90 
days, and 24.5% were readmitted for the first time between day 91 and 365 after 
discharge. Of the 943 patients that could be followed for one year, a total of 355 patients 
(37.7%) were readmitted at least once within one year. The most frequent causes of 
readmission during both periods were infections, recurrent stroke, cardiac disease, and 
stroke-related event. Early readmission was associated with increasing age (OR=1.02, 
95% CI = 1.00-1.03), poorer functional outcome (OR=1.21, 1.09-1.35), LAA subtype 
(OR=1.85, 1.17-2.92), atrial fibrillation (OR=1.54, 1.08-2.19) and increasing risk factor 
burden (OR=1.28, 1.08-1.51). Late readmission was associated with increasing age 
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(OR=1.02, 1.00-1.03) and prior myocardial infarction (OR=1.89, 1.18-3.04), whereas 
SVO subtype had a lower risk of late readmission (OR=0.56, 0.31-0.98). Early 
readmitted patients had a shorter length of stay during the index admission, poorer 
physical function and higher frequencies of LAA subtype, atrial fibrillation, and 
complications with infection during the index admission compared to patients 
readmitted late. More patients were readmitted with recurrent ischemic stroke or 
myocardial infarction within the first 90 days compared to the following 90 days (n=34 
versus n=12, P=0.02). Pneumonia during the index admission significantly increased the 
risk of readmission for pneumonia within 90 days and from day 91-365, and urinary 
tract infection or urinary retention significantly increased the risk of readmission due to 
urinary tract infection within 90 days. 
 
Paper III: Hospital readmission within one year versus the second and fifth year 
The study included 1453 patients with ischemic stroke or TIA, of whom 568 (39.1%) 
were readmitted within one year. Of the 830 patients that were alive and without 
readmission one year after discharge, 439 (52.9%) were readmitted within five years. 
The most frequent cause of readmission during the first year was infections, followed 
by recurrent stroke and stroke-related event, whereas cardiac disease and infection 
were the most frequent cause of the first readmission for patients readmitted from the 
second through fifth year. Common independent risk factors of readmission within 
one year and from the second through fifth year were increasing age (HR=1.02, 95% 
CI = 1.01-1.03, and HR=1.03, 1.02-1.04, respectively), poorer functional outcome 
(HR=1.15, 1.09-1.22, and HR=1.09, 1.02-1.16, respectively), coronary artery disease 
(HR=1.29, 1.07-1.57, and HR=1.50, 1.20-1.89, respectively) and hypertension 
(HR=1.26, 1.05-1.50, and HR=1.38, 1.13-1.68, respectively). Peripheral artery 
disease was independently associated with readmission within the first year 
(HR=1.42, 1.06-1.89), and atrial fibrillation was associated with readmission from the 
second through the fifth year (HR=1.25, 1.01-1.55). Patients with SVO subtype had a 
significantly lower risk of readmission during the first year (HR=0.67, 0.49-0.91). 
Patients readmitted during the first year after discharge were older, had more severe 
 47 
strokes, a poorer functional outcome, and a higher occurrence of complications 
during the index admission than patients readmitted from the second through the fifth 
year. Cardiovascular comorbidity and prescribed medication at discharge or at the 
time of readmission did not differ between the two groups of readmitted patients. 
 
Paper IV: Five-year hospital readmission and mortality by stroke subtype 
The five-year incidence of all-cause readmission after ischemic stroke or TIA was 
72.6% (74% LAA, 81% CE, 65% SVO, 55% SOE, and 68% SUE). Stroke patients 
with CE or SVO had the highest admission and discharge NIHSS score, respectively, 
and the poorest short-term functional outcome. Stroke patients with LAA had the 
highest risk factor burden, and the highest occurrence of peripheral artery disease, 
hypertension, and smoking. The most frequent causes of readmission were infections 
(30%), cardiac disease (20%), stroke-related event (15%), recurrent stroke (14%), and 
fracture (12%). Table 2 demonstrates the cumulative incidence of all-cause and cause 
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The incidence of readmission due to infection, cardiac disease, and fractures varied 
significantly among the stroke subtypes. There was no difference in the incidence of 
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recurrent stroke or stroke-related events among the stroke subtypes. After adjusting 
for age, sex, mRS score, premorbid care-status, and the risk factor burden, SVO 
subtype had a 21% lower risk of all-cause readmission (HR=0.79, 0.64-0.98), and CE 
subtype had a 25% higher risk of all-cause readmission (HR=1.25, 1.09-1.43). CE 
subtype also had a 75% higher risk of readmission due to cardiac disease (HR=1.75, 
1.35-2.25), whereas SUE was associated with a 23% lower risk of readmission due to 
cardiac disease (HR=0.77, 0.59-0.99). 
After five years, 404 (40.1%) of the readmitted patients were dead compared to 88 
(19.7%) of patients that had not been readmitted (p<0.001). The five-year mortality 
varied significantly among stroke subtypes, with the highest mortality observed in 
patients with CE. After adjusting for age, sex, mRS score, premorbid care-status, and 
the risk factor burden, CE subtype had a 34% higher risk of death within five years 




Prevalence and causes of readmission after ischemic stroke and TIA 
The focus on hospital readmission after stroke has dramatically increased since 
readmission became an established indicator of the quality of care. Stroke patients are 
considered as an important patient group contributing to readmissions and have been 
the main focus of many studies. Our study provides evidence that readmission after 
stroke is frequent also in a Norwegian stroke population, especially in the early phase 
following discharge, as more than half of our patients that were readmitted within one 
year presented during the first three months. Other studies vary slightly in the 
frequency of readmitted patients but show similar trends for the timing of 
readmissions.102-105 The early phase after stroke might thus be regarded as a 
particularly vulnerable and unstable period. Regardless of the initial admission 
diagnose, it has been argued that the increased risk of readmission in the early phase 
after discharge may be caused by an acquired condition of vulnerability, a so-called 
“post-hospital syndrome”.150 During hospitalization, different stressors of physical, 
environmental and psychological nature may trigger pathophysiological and multi-
systemic responses such as hypercatabolism, hypercoagulability, immunosuppression 
and increased sympathetic activity. This may cause progression of the disease that 
caused the hospital admission or trigger deterioration of comorbidities. Furthermore, 
new clinical or surgical conditions may emerge. This theory is based on the fact that 
many readmission causes often differ from what caused the initial hospitalization, and 
often include heart failure, pneumonia, other infection, gastrointestinal conditions, 
and metabolic derangements regardless of the original admitting diagnosis.98, 150 
Table 3 summarizes readmission rates in other studies compared to the rates found in 
our studies. Although the reported rates from other studies vary widely in all periods, 
the NORSTROKE cohort is in the lower range of readmission. Large variations in 
readmission rates may occur due to differences in study populations, exposure, 


































In our study, 10.7% of our ischemic stroke and TIA patients were readmitted within 
30 days. Thirty-day readmission after stroke is a national quality indicator in Norway, 
and from 2014 to 2016, 11.4% of all Norwegian stroke patients aged 67 years or 
older were readmitted within 30 days.4 In the same period, the readmission rates after 
pneumonia, heart failure or chronic obstructive pulmonary disease (COPD) ranged 
from 21% to 28%.4 It might be that more stroke patients are discharged to nursing 
homes rather than to a home situation, leading to lower readmission rates than for 
some other conditions. The number of new patients presenting with readmission 
decreases in the period beyond one year after stroke.113 Even though the majority of 
all readmitted patients in our study presented during the first year after discharge, 
more than half of all patients that survived for one year after stroke without any 
readmission were readmitted within five years. About 20% of all stroke patients are 
readmitted each year up to five years, but the number decline to 9% readmitted each 
year later than five years post stroke.159 In 2017, Rohweder et al. published a study on 
readmission within ten years in 243 stroke patients from another Norwegian stroke 
center and found that the readmission rates stabilized and were almost similar to the 
distribution of readmission in the general population from year five to ten after 
stroke.106 A possible explanation for why the readmission rates reach the background 
level of the general population after five years post-stroke might be that the most 
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severely affected patients, who have both the highest risk of readmission and the 
poorest long-term survival, are dead five years after the stroke.160 
The most frequent causes of hospital readmission after stroke are infections, recurrent 
stroke, and other cardiovascular diseases.105, 113 Our studies confirm that all of these 
are common causes of readmission after stroke, but we also show that stroke-related 
events, with the majority being stroke mimics or worsening of existing symptoms, is 
another common cause of readmission. Furthermore, we show that these causes are 
not only prevalent in the acute phase but remains important also in the long run.  
 
Recurrent stroke and stroke mimics 
Recurrent stroke was one of the top causes of readmission. The incidence, however, 
was low compared to studies on recurrent stroke incidence.161, 162 In a meta-analysis 
of 13 studies, the pooled cumulative stroke recurrence risk was 3% at 30 days, 11% at 
one year, 26% at five years, whereas the incidences in our studies were almost half of 
this at the reported time points (Table 2).162 Some evidence point to a decline in 
recurrent stroke incidence, which could explain these discrepancies. The meta-
analysis found a temporal reduction in five-year recurrence from 32% in the 1960s to 
16% in the early 2000s, and a Swedish study found a declining incidence of one-year 
stroke recurrence from 15% in 1998-2001 to 12% in 2007-2010.162, 163 However, the 
most recent and largest meta-analysis to date found no significant decline in the risk 
of stroke recurrence after ischemic stroke or TIA.114 In our study, 11.3% suffered a 
recurrent ischemic stroke within five years, which is comparable to the 9.5% found in 
a recent study including 3847 patients with minor stroke or TIA.115 The combined 
five-year incidence of any recurrent stroke or TIA in our study was 13.8%, which is 
somewhat lower than 16.8% found in the other study, but the incidence of recurrent 
TIA was 8.3% in that study and only 2.0% in ours. 
The average annual risk of recurrence after ischemic stroke or TIA is about 4.3%, 
with a particularly high risk during the first weeks which declines significantly over 
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time.114, 161 We found a significantly higher risk of early recurrence in patients with 
LAA subtype, with 4.5% suffering a recurrent stroke within 30 days compared to the 
average 1.8%. Other studies have shown that the risk of recurrent stroke is almost 
doubled in patients with LAA up to one year after stroke.144, 164 The reason for the 
increased risk of recurrence in patients with LAA is not fully understood, but the 
most likely explanation is that patients with LAA suffer repetitive shedding of 
thrombi from unstable atherosclerotic plaques triggered by shear stress in stenotic 
parts of the artery.165 Also, cerebral ischemia may be induced by carotid surgery in 
some patients.144 Both in our study and other studies, the distribution of recurrent 
stroke risk stabilizes among the stroke subtypes in the long-term perspective.34, 166-168 
This might nevertheless be influenced by age and mortality in a general stroke 
population, as the risk of recurrent stroke remains significantly increased in the long-
term perspective when restricting the analyses to younger stroke patients.169 
Many of the factors that were identified as risk factors for readmission in our studies, 
such as increasing age, previous vascular events, hypertension, ipsilateral large-artery 
atherosclerosis, and atrial fibrillation, are important risk factors for recurrent stroke.91, 
115, 163 A study on one-year recurrence in almost 200, 000 Swedish patients with 
ischemic stroke between 1998 and 2009 found that warfarin treatment for atrial 
fibrillation, lipid-lowering medication, and antithrombotic therapy reduced the risk of 
recurrent stroke.163 Accumulating evidence shows the clear benefit of antiplatelet 
medication, anticoagulation, blood pressure control, and lipid-lowering drugs. 
Clinical trials on secondary prevention have demonstrated risk reductions in stroke 
recurrence of 27% for antihypertensive treatment,70 16% for lipid-lowering 
medications,71 30% for antiplatelet medication,170 and 68% for anticoagulation 
treatment.80 However, the largest meta-analysis in the field of recurrent stroke found 
no significant decline in the stroke recurrence rate despite considerable improvement 
in secondary prevention with medical treatment and a reduction in stroke risk 
factors.114 This implies that there still exists room for improvement, especially when 
it comes to insurance of adherence to medications and compliance. Furthermore, even 
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though it is challenging to implement lifestyle changes, this is highly important in 
younger stroke patients.  
Educational campaigns in Western Norway have led to a higher recognition of 
conditions that could represent stroke.171 One should have a low threshold for 
admitting patients with sudden onset of neurological symptoms, including patients 
with previous stroke that experience worsening of or new neurological symptoms due 
to their high risk of recurrent stroke.113 Readmissions due to events related to the 
initial stroke were common during all periods measured in our studies. During the 
first month after discharge, a high number of patients were readmitted with possible 
stroke where the symptoms were evolving stroke, aggravation of existing 
neurological deficits or stroke sequela. The few studies that have reported the number 
of patients readmitted with stroke-related events have found that such conditions are 
important contributors to readmissions within the first year after stroke.95, 103, 172 
Distinguishing between stroke and stroke-like syndromes is difficult, and stroke 
mimics (false-positive stroke diagnosis) represents approximately 50% of all patients 
admitted with suspected stroke.173 Increasing stroke severity has been related to the 
risk of readmission with neurological sequela after stroke.172 Experience from clinical 
practices suggests that in situations where older and disabled patients that have 
previously suffered a stroke present with a slight worsening of stroke sequela, there is 
a larger possibility that the symptoms are caused by other conditions than stroke, like 
infections, sleep-disturbances, or adverse effects of medications. Retrospectively one 
could suggest that some of these readmissions could have been avoided. However, a 
reduction in the stroke mimics rate could potentially lead to an increase in the number 
of underdiagnosed stroke cases.173 Even though it would remove some pressure on 
the hospitals if one could avoid some hospital readmissions or admission related to 
stroke mimics, a low threshold for admitting patients with acute onset of neurological 
symptoms should be valued, and it is highly uncertain whether it would be beneficial 
to avoid such readmissions even though the final diagnose is not recurrent stroke.  
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Vascular events and cardiac disease 
Recurrent ischemic stroke was considerably more frequent than myocardial infarction 
in our study, with an incidence of myocardial infarction of 0.3% at 30 days and 6.9% 
at five years. This finding is consistent with both randomized clinical trials and 
population-based studies.161, 174, 175 In 2018, a meta-analysis including 58 studies on 
recurrent stroke, myocardial infarction and vascular deaths in patients with ischemic 
stroke or TIA between 1976 and 2014 found an annual risk of myocardial infarction 
after ischemic stroke or TIA in 1.7%, and 3.6% in patients with known coronary 
artery disease.114 In addition to coronary artery disease, male sex, hypertension, and 
peripheral artery disease were identified as risk factors for myocardial infarction after 
ischemic stroke or TIA. The study also found a temporal decline in myocardial 
infarction after stroke, as stroke patients enrolled in studies later than 2005 had an 
annual risk of myocardial infarction of 0.9%. Similar trends have been demonstrated 
in the general population.176 The reduction in myocardial infarction after stroke is 
likely caused by a decline in the prevalence of cardiovascular risk factors and better 
treatment of modifiable risk factors.114, 176  
In 1998, the AHA/ASA published a statement suggesting that atherosclerotic stroke 
should be considered as a high-risk condition for atherosclerotic coronary events and 
included in risk prediction tools for cardiovascular diseases.118 The number of studies 
reporting on stroke subtypes and the risk of myocardial infarction is low, but overall, 
no difference between the stroke subtypes has been demonstrated.114 In our study, the 
highest incidence of myocardial infarction at five years was found in patients with 
LAA, but neither did we show any differences between the stroke subtypes. Some 
studies have found that LAA subtype is associated with a generally increased risk of 
new vascular events, including both stroke, coronary artery disease and peripheral 
artery disease.177, 178 Atherosclerosis is a systemic disease and a shared mechanism for 
coronary artery disease, peripheral artery disease, and atherosclerotic stroke subtype. 
However, studies show conflicting results between stroke subtype, the prevalence of 
cardiovascular risk factors, and the risk of new vascular events.30, 32, 33, 115 This 
suggests that the stroke subtypes should have the same preventive strategies based on 
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their presence of vascular risk factors, and that assessment of traditional 
cardiovascular risk factors and concurrent coronary artery disease and peripheral 
artery disease to determine the atherosclerotic burden might be helpful in predicting 
the risk of new vascular events in patients with ischemic stroke or TIA.178 
Cardiac disease, including myocardial infarction, represented about 12% of all 
readmissions within 30 days, and 11% of all first readmission within one year in our 
studies. At five years, almost 21% had been readmitted due to cardiac disease. 
Besides from myocardial infarction, arrhythmias and congestive heart failure were 
the most common cardiac diseases causing readmissions, with five-year incidences of 
7% and 5%, respectively. Both were significantly more common in patients with CE 
subtype, which had an overall increased risk of readmission due to heart disease at 
both 30 days and five years. The relationship between cardioembolic stroke and 
readmission due to cardiac disease is clear, as these patients have an underlying 
cardiac disease which caused the ischemic stroke or TIA. Furthermore, CE subtype is 
associated with high age,32 and the occurrence of both arrhythmias and congestive 
heart failure increases with age.179, 180 Patients with stroke are at increased risk of 
readmission with heart failure compared to the general population, and about 3-5% of 
ischemic stroke patients are readmitted with heart failure annually.105, 113  
Readmission due to venous thromboembolism (VTE) was a rare event in our cohort, 
with a five-year incidence of only 1.6%. The risk of VTE is especially high during 
the first weeks after ischemic stroke and TIA, probably due to immobilization and 
enhanced activity in the coagulation system.119 About 0.4% of the patients in 
NORSTROKE develop either DVT or pulmonary embolism during the index 
admission, and only 0.2% of our patients were readmitted with VTE during the first 
30 days. In a Norwegian study of 489 stroke patients, DVT or pulmonary embolism 
occurred in 0.6% each during the first week after stroke onset.181 However, the true 
incidence of VTE both during the index admission and after discharge is probably 
higher. A prospective study including 102 ischemic stroke patients found that 3% 
developed clinical DVT and 5% developed clinical pulmonary embolism within 21 
days, but VTE was detected in 40% by use of MRI direct thrombus imaging.182 
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Furthermore, half of the clinically evident VTEs were overlooked by the attending 
team.182 Venous thromboembolism was previously one of the most frequent 
complications of ischemic strokes, but with increasing attention towards early 
mobilization and more frequent and effective use of antithrombotic prophylaxis in 
high-risk patients, the rates of symptomatic VTE have declined.182  
 
Infections 
Infection was the most frequent cause of readmission after five years in our study, 
and also a dominating cause of readmission during the first months after discharge. 
Other studies show that infections are the cause of 12-34% of early readmissions and 
15-44% of all readmissions within one year.95, 103, 104, 158 We found that infections 
caused 17% of all first readmissions after ischemic stroke and TIA during the first 90 
days and 19% within one year. After five years, about 30% had been readmitted with 
an infection, with an especially high proportion during the first 30 days. The high 
vulnerability of infections in the early phase after stroke can relate to acute stroke-
induced immunosuppression or the hospitalization with nosocomial infections and 
physical insults like urinary catheterization and mechanical ventilation. In some 
cases, early infections may also have been acquired before stroke onset, with a 
subsequent worsening of symptoms after stroke onset.183 
Most post-stroke infections in our studies involved the urinary tract or the respiratory 
system. Pneumonia and urinary tract infections (UTI) occur in approximately 10% of 
stroke patients in the acute phase each and continue to affect stroke patients in the 
long-term perspective.93, 107 Within five years, 15% of our patients had been 
readmitted with pneumonia, and 9% had been readmitted with UTI. Shared risk 
factors for post-stroke pneumonia or UTI are increasing age and severe strokes.110, 183, 
184 Male sex is associated with post-stroke pneumonia, whereas female sex is 
associated with post-stroke UTI.110, 183, 184 Urinary catheterization increases the risk of 
UTI and should be avoided if possible, or removed as soon as possible or replaced by 
intermittent catheterization or other alternatives.185 Factors associated with post-
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stroke pneumonia are use of a nasogastric tube or mechanical ventilation, diabetes 
mellitus, chronic obstructive pulmonary disease, and smoking.183 The most consistent 
risk factor for developing pneumonia after stroke, however, is dysphagia, increasing 
the risk by a three-fold.183, 186 Dysphagia with secondary aspiration is thought to be 
the cause of most pneumonia occurring after a stroke. Depending on the diagnostic 
technique, dysphagia occurs in 37% to 78% of all stroke patients, half of whom 
aspirate.186, 187 Formal screening for swallowing difficulties and appropriate dietary 
modifications are therefore important to prevent post-stroke pneumonia.188 Most 
patients with swallowing difficulties have spontaneous improvement in swallowing 
function, but dysphagia can also be long-lasting.189 Although nasogastric tube or 
percutaneous endoscopic gastrostomy should be provided in patients with dysphagia 
due to nutritional reasons, neither offers any protection against aspiration 
pneumonia.190 Prolonged use of nasogastric tube may have an adverse effect and 
should be replaced by a percutaneous endoscopic gastrostomy in individuals who 
remain unable to swallow. Furthermore, the use of prophylactic peptic ulcer 
medications after stroke have been associated with hospital-acquired pneumonia and 
should perhaps be avoided in patients who are not at high risk of developing peptic 
ulcers.191  
Several studies have investigated the effect of prophylactic antibiotic treatment.192-195 
In a Cochrane review from 2018 including eight randomized controlled trials on 
prophylactic antibiotic treatment in stroke patients, the overall occurrence of infection 
fell from 26% in the control groups to 19% in patients that received prophylactic 
antibiotic treatment.196 The decline was mainly driven by a reduction of UTIs, and no 
effect was found on the prevention of pneumonia. To date, no studies have shown a 
beneficial effect of prophylactic antibiotic treatment on functional outcome or 
mortality, and prophylactic treatment is not recommended for any subgroups of 




We found that readmission with fracture was more common in the phase beyond the 
first six months. This has also been demonstrated in other studies.105, 106, 129, 197 In two 
large studies from the UK, about 10% of stroke patients had been admitted with a 
fracture within ten years.136, 198 The incidence of patients readmitted with fractures 
was considerably higher in our study, as about 12% had been readmitted with any 
fracture within five years. Furthermore, some types of fractures are usually treated in 
primary care and do not require hospitalization, and the true incidence of any 
fractures in our population is likely higher. The rate of hip fractures in Norway, 
which is a serious condition with high mortality in the elderly, is among the highest in 
the world.199, 200 Hip fractures usually require hospitalization, and almost 7% had 
been readmitted with hip fracture within five years in our study. The reason for the 
high occurrence of fractures in Norway and Scandinavia is probably multifactorial, 
but not fully understood. As stroke patients have considerably increased rates of 
fractures compared to the general population, careful assessment for risk of falls and 
treatment of osteoporosis is crucial in stroke patients.113, 129, 197 Prevention of falls 
require multifactorial risk assessment and simultaneous management with exercise to 
improve mobility.201 Early mobilization is also important to prevent increased bone 
resorption after stroke. A small Norwegian study of 40 patients found significant 
differences in bone mineral density in stroke patients who learned to walk within one 
year after stroke.202 Vitamin D2 supplementation can be useful for fall-prevention in 
stroke patients as it might reduce muscle atrophy, and supplementation with 
bisphosphonates increases the bone mineral density after stroke.131, 203, 204 Calcium is 
a major component of bone, and sufficient intake of calcium is recommended for 
prevention of osteoporosis; however, studies show conflicting results on its 
effectiveness for prevention of fractures in stroke patients, and there have been 
concerns that calcium supplementation might have adverse cardiovascular effects.205, 
206 A final medical approach for reducing hip fractures is supplementation with folate 
and vitamin B12, which showed beneficial effects in the risk of fractures in a 
randomized controlled trial of 628 elderly Japanese stroke patients.207  
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Seizures and epilepsy 
The long-term risk of post-stroke epilepsy after ischemic stroke ranges from 2% to 
5%.126, 128, 208 The five-year incidence of readmission with seizure or epilepsy was 
4.3% patients in our cohort, which is higher than the 3.1% patients that developed 
epilepsy in another Norwegian study of 484 ischemic stroke patients followed for 7-8 
years.127 We do not know the exact amount of patients diagnosed with epilepsy in our 
cohort, as secondary diagnoses and medical treatment have not been included in our 
studies, and some patients may have been referred to the outpatient clinic.  
Post-stroke epilepsy has traditionally been defined as two or more unprovoked 
seizures occurring later than one week after an ischemic stroke; however, according 
to the new definition from the International League Against Epilepsy, epilepsy can be 
diagnosed after a single unprovoked seizure if other findings support that the risk of 
further seizures equals the risk seen after two unprovoked seizures over the following 
ten years (at least 60%).209, 210 Even though stroke patients in general have a relatively 
low risk of seizures and none of the identified risk factors for post-stroke epilepsy are 
strong enough to initiate prophylactic AED treatment, this category may apply to 
some stroke patients with late unprovoked seizures according to the new 
definition.128, 211  
 
Gastrointestinal bleeding 
Gastrointestinal (GI) bleeding was previously among the more common 
complications after stroke, occurring in about 3-5% during stroke hospitalization, but 
newer studies report lower rates of about 1.5%.2, 137, 138 The five-year incidence of 
readmission with GI bleeding was 4.4% in our cohort. A case-control study found 
that 5.2% of ischemic stroke patients were readmitted with GI bleeding within five 
years, whereas only 1.4% of patients without stroke were admitted with GI bleeding 
during the same period.113 Stroke patients are at higher risk of GI bleeding than non-
stroke patients due to treatment with anticoagulants or antiplatelet therapy and shared 
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factors for ischemic stroke and GI bleeding.212, 213 About half of all GI hemorrhages 
in stroke patients are severe.2, 137 Post-stroke GI bleeding is associated with higher 
rates of dependency and mortality, which might relate to the immediate consequences 
of the bleeding, but also to other factors associated with post-stroke GI-bleeding, such 
as high age, severe stroke, cancer, and sepsis.137, 138 Other factors that are associated 
with post-stroke GI bleeding are history of peptic ulcers and hypertension, whereas 
preadmission use of antithrombotic treatment or proton pump inhibitors or 















The impact of stroke subtype on readmission after stroke and TIA 
Our studies demonstrate that readmission after stroke varies among the different 
subtypes. LAA and SOE subtype were associated with the highest risk of readmission 
within 30 days, whereas CE subtype had the highest risk of readmission at five years. 
SOE subtype was associated with a lower risk of readmission within five years. Few 
other studies on readmission after stroke have included ischemic stroke subtype.95, 104, 
214, 215 A retrospective study of 265 ischemic stroke or TIA patients found no 
difference in the risk of 30-day readmission among the stroke subtypes, whereas a 
study of 987 young stroke patients included in the late 1980s and followed until 2009, 
found a significantly increased risk of readmission for the CE subtype.214, 215 Other 
studies have reported that LAA or CE subtype independently increases the risk of 30-
day readmission and that the CE subtype increases the risk of one-year readmission.95, 
104 All of these studies were, however, smaller than ours, and to our knowledge, our 
cohort is the largest to date where the risk of readmission has been investigated by 
stroke subtype. 
Differences in the rates and risk of readmission among stroke subtypes are reflected 
in the frequency of different causes of readmission. The high occurrence of recurrent 
stroke and stroke-related events within 30 days associated with LAA and SOE 
subtype probably explains why these patients had a higher risk of 30-day 
readmission. The same accounts for patients with CE subtype, which had higher risks 
of readmission with cardiac disease at five years, and high rates of infections, 
fractures, seizures, and stroke-related events. CE subtype is associated with high age, 
severe strokes, and poor outcome, which subsequently can increase the risk of 
infections, fractures, and seizures after stroke.32, 33 The underlying cardiac disease 
naturally increases the risk of readmission with cardiac disease, and blood pressure 
alterations may lead to falls and fractures.216 Since the 1980s, the rate of stroke 
caused by CE has tripled, and are projected to increase further.217 As our results as 
well as the results from other studies show that CE strokes carry a high risk of poor 
outcome with hospital readmission and death, early diagnosis together with 
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appropriate treatment and careful monitoring and handling of patients with CE is 
crucial.178, 215, 218 
Stroke etiology combined with differences in risk factor profile and stroke severity 
likely predispose for different diseases at various degrees. It is possible that factors 
not investigated in our studies may explain the detected differences in rates and 
causes of readmission after ischemic stroke and TIA. Our results need validation 
from other studies, but they suggest that stroke subtype may provide useful 




Risk factors for hospital readmission after ischemic stroke and TIA 
Risk factors for hospital readmission after stroke is a disputable topic investigated by 
many studies with differences in study population, study design and length of follow-
up. Despite the limited comparability between studies, some factors are repeated, 
including age, increasing stroke severity, functional disability, longer hospital stay, 
diabetes mellitus, and an increasing number of hospitalizations prior to the stroke 
admission (Table 4). It is plausible that risk factors related to early readmissions after 
stroke may differ from risk factors for readmission in the subacute and chronic phase, 
as complications and provided health care may to a larger extent contribute to early 
readmissions, whereas readmissions beyond the acute phase may relate more to 
comorbidity in stroke patients. However, our studies provide evidence that many of 
the factors associated with readmission in the acute and subacute phase, such as 
increasing age, poor functional outcome, atrial fibrillation and atherosclerotic disease 
in other sites than the cerebrovascular one, is also associated with readmission in the 
































































































































































































































































































































































































































Age was the most consistent risk factor for readmission in our studies, increasing the 
risk of readmission about 2-3% for each aging year. As the majority of stroke patients 
are 75 years of age or older, one can argue how useful age is in predicting the risk of 
readmission.5 However; it implies that for each tenth aging year, the risk of 
readmission increases between 20-30%. With aging comes a gradual decrease in 
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physical and mental capacity and a growing risk of disease and an increased risk of 
several conditions at the same time, and a decreased ability to compensate for acute 
diseases.  
Hypertension, coronary artery disease, and peripheral artery disease were associated 
with readmission in both the subacute phase and in the chronic phase. These are also 
consistent factors for readmission in many other studies (Table 4). Hypertension is 
one of the main risk factors for stroke and cardiovascular disease, and coronary artery 
disease and peripheral vascular disease are manifestations of systemic atherosclerosis.  
Presence of these conditions increased the risk of readmission as recurrent stroke and 
cardiac disease were among the top causes of readmission. Special attention towards 
optimizing management of other underlying medical conditions, especially 
hypertension, coronary artery disease, and peripheral vascular disease, might thus be 
helpful to reduce readmissions after stroke. Hypertension is probably the most 
important modifiable risk factor, and systolic and diastolic blood pressure reduction is 
linearly related to a lower risk of recurrent stroke, myocardial infarction, all-cause 
mortality, and cardiovascular mortality after stroke.70 We did not find that 
prescription of treatment with antihypertensive treatment, platelet inhibitors, 
anticoagulation or statins affected the risk of five-year readmission. However, as we 
do not have information on medical treatment after discharge in patients that were not 
readmitted, we cannot conclude that such treatment was ineffective. 
Increasing comorbidity is among the most consistent risk factors for readmission in 
stroke patients, as well as in the general population.139, 140, 172, 223 Many other studies 
have included general comorbidity scores, such as the Charlson Comorbidity Index 
(Table 4), but we did not have sufficient information to generate a general 
comorbidity score. However, the risk factor burden, which was constructed from six 
traditional cardiovascular risk factors, has been associated with an increased risk of 
recurrent stroke.145 We found that an increased risk factor burden was significantly 
associated with readmission in the subacute phase, and although we did not include 
risk factor burden in the multivariate analyses of other time-intervals due to 
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collinearity with other included variables, readmitted patients had a higher risk factor 
burden than patients that were not readmitted.  
Poor functional outcome was an independent risk factor for readmission both in the 
subacute and chronic phase in our studies. We also found that patients readmitted 
early tended to have poorer functional outcome than those who experienced the first 
readmission later. Neurological deficits and the functional outcome often improve 
during the first year after discharge, and the predictive value of the short-term mRS 
score in our study may thus be limited. Almost 65% of all Norwegian stroke patients 
have an mRS score of 0-2 after three months.51 The post-stroke functional outcome 
depends on stroke severity and premorbid function, which has been associated with 
early readmission after stroke.140 We found that more patients readmitted within five 
years received home nursing before the stroke, but more of the patients that were not 
readmitted within five years were permanently institutionalized prior to the ischemic 
stroke or TIA. Poor post-stroke functional outcome has been associated with 
readmission in some studies, but most studies usually include stroke severity rather 
than functional outcome, which is consistently associated with readmission (Table 4). 
Patients that were readmitted had more severe strokes than patients without 
readmission in all our studies, but due to collinearity with functional outcome and 
generally low NIHSS scores compared to other studies, we did not include stroke 
severity in the multivariate analyses. We do not have a good explanation for the low 
NIHSS score in our population, but the same trends are observed in the national 
Norwegian stroke registry, where about 65% of all patients have an NIHSS score of 5 
or less, and 41% have an NIHSS score of 2 or less.51 The average NIHSS score may 
also be affected by the inclusion of TIA patients and exclusion of patients that died 
before discharge or were discharged to palliative care. The low stroke severity in the 
Norwegian population may be a result of national population-based stroke campaigns 
and that the hospitals have a low threshold for admitting patients with acute 
neurological symptoms. Furthermore, 94% of all Norwegian stroke patients are 
treated in stroke units, which has been documented to improve functional outcome in 
stroke patients.51, 227  
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Although complications are most common in patients with severe strokes and 
generally poor outcome, it remains a risk factor for readmission after adjusting for 
such confounders.103, 140, 172 In our analysis, complications during index admission 
were associated with 30-day readmission in univariate analyses, whereas enteral 
feeding was the only complication that was an independent risk factor for 30-day 
readmission. Enteral feeding is associated with an increased risk of pneumonia, 
gastrointestinal bleeding, and also indicates more severe strokes. Pneumonia or 
urinary tract infection during the index admission significantly increased the risk of 
readmission with the same infection within 90 days. In a recent study from the 2013 
National Readmission Database in the US, 29% had an infection during the index 
admission, and the odds of an unplanned 30-day readmission was 23% higher in 
patients with infections.228 The study also found that only 14% of the stroke patients 
that were readmitted for an infection did not have an infection during the index 
admission.228 We found that complications were more frequent in patients readmitted 
early. A likely explanation is that patients with complications have more severe 
strokes which increases the risk of readmission, and that complications have an 
adverse impact on the functional outcome. It is also likely that some of these patients 
are predisposed to certain infections. However, some of the readmissions might be 
directly related to the complication, and some patients may have been discharged too 
early.95 
The length of stay is affected by many factors including stroke severity, pre- and 
post-stroke function, and occurrence of complications. Shorter length of stay have 
been associated with an increased risk of 30-day readmission in elderly Norwegian 
patients.229 However, longer length of stay have been associated with readmission 
after stroke in several studies (Table 4). A possible explanation for this might be that 
patients with long hospitalizations have more severe strokes and more complications. 
We found no difference in the length of stay between readmitted and not readmitted 
patients in any of our studies. A reduction in the length of stay in Norwegian 
hospitals has been observed after the implementation of the Norwegian Care 
Coordination Reform (Samhandlingsreformen) in 2012, but there has also been a 
slight increase in the overall 30-day readmission rate.99 The focus on rapid discharge 
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after complete evaluation and treatment might have led to some premature 
discharges. Despite that many readmissions are unavoidable, awareness and proper 
care during the stroke admission, despite causing longer hospitalizations, would be a 
better alternative than rapid discharge and early readmission. 
Patients with ischemic stroke are usually considered having a worse prognosis than 
patients with TIA, but TIA patients had the same risk of readmission as patients with 
ischemic stroke in our studies. There are conflicting results whether TIA patients 
have lower, similar or higher rates of readmission than ischemic stroke patients, 
which could be due to differences in use of secondary prevention and adherence to 
medical treatment.157, 214, 225 TIA patients have the same risk factor profile and 
underlying causes of their ischemic event as patients with ischemic stroke, and likely 
the same risk for many diseases despite no permanent neurological dysfunctions. This 
emphasizes the importance of attention towards comorbidity and aggressive and 
accurate secondary treatment in order to reduce readmissions after TIA. 
In 2013, Lichtman and colleagues published a retrospective cohort study of about 
300 000 ischemic stroke patients. Based on predefined criteria for preventable 
readmissions, they found that 1.7% of all discharges were followed by preventable 
readmissions within 30 days, representing 12% of all readmissions within 30 days. 
Preventable readmissions were associated with high age, female sex, cardiovascular 
comorbidity, pneumonia, dementia, anemia, and malnutrition.230 Another study found 
that increasing comorbidity, insurance type, and mental illness were associated with 
potentially preventable readmissions, which represented 8.4% of all 30-day 
readmissions after stroke.231 Some of the factors that we have found to be associated 
with readmission, such as age and history of atherosclerotic disease, are hard to 
influence, but other factors like acute complications, hypertension, atrial fibrillation, 
and possibly functional outcome, are modifiable and can be targeted to improve both 
early and late readmissions. 
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The impact of hospital readmissions on mortality 
Hospital readmission has been hypothesized a risk factor for death after stroke. In our 
study, readmission within 30 days was an independent risk factor for death within one 
year after stroke. This finding is consistent with that of a large US study, and smaller 
studies have also found similar trends.3, 152, 232 In paper IV we demonstrate that a 
significantly higher proportion of patients readmitted within five years had died, 
compared to those who had not been readmitted. Readmissions later than 30 days 
after discharge probably also affect mortality. This was shown in a study of 356 
patients with intracerebral hemorrhage in Portugal, where readmission within one 
year led to a five-fold increase in two-year mortality.233 A reason for the mediating 
effect readmission has on mortality might be that post-stroke complications requiring 
hospital readmissions lead to higher disability. Less severe complications, such as 
urinary tract infections and simple fractures can be treated in primary health care, 
while more severe complications require hospitalization. Pneumonia, sepsis, vascular 
events, heart failure, and hip fractures were all frequent causes of readmission, and all 
increase the post-stroke mortality.90, 112, 234 Another reason for the increased risk of 
mortality in patients that are readmitted early after stroke might be that an unplanned 
hospital admission can interfere with rehabilitation, and delay, reduce or even inhibit 
recovery after stroke. A third explanation that also interferes with the two other 
explanations might be that the stroke patients that are readmitted have a worse 
prognosis already at the index admission. It might be that with declining in-hospital 
mortality, patients that previously would not have survived the hospitalization are 
now discharged alive. Furthermore, these patients might be older, more disabled, and 
fragile, all of which are associated with increased mortality. Several risk factors for 
post-stroke readmission also increases the risk of death, such as high age and severe 
stroke. Thus, readmission and death might be correlated in the sense that the stroke 




Future perspectives - preventing readmissions 
Reducing hospital readmissions requires complex, multifaceted and validated 
strategies, all of which still needs to be further explored. Reducing hospital 
readmissions has become a top priority in the United States after the Hospital 
Readmissions Reduction Program was established in 2012. The program financially 
penalizes hospitals with a higher than expected risk-standardized 30-day readmission 
rate.235 The program has led to a decline in 30-day readmission rates from 21.5% in 
2007 to 17.8% in 2015 for the targeted conditions, whereas readmission rates in non-
targeted conditions declined from 15.3% to 13.1%.236 However, the program has 
received criticisms both for disproportionally penalizing hospitals that care for 
vulnerable populations and increasing post-discharge mortality, as recent studies have 
found an increase in 30-day and one-year mortality after pneumonia and heart failure 
simultaneously with the decrease in 30-day readmission rates.235, 237-239 
Use of prediction tools could help target the delivery of health services, and 
contribute to reducing the number of readmissions.139 Prediction tools could either be 
based on readmission risk regardless of the initial admission cause, or disease-
specific prediction tools such as the risk of readmission after stroke. One could also 
use prediction tools for all-cause readmission, or prediction tool for specific causes of 
readmission. Increasing age, disease severity, prior healthcare utilization and 
complications during index admission are associated with both generic and disease-
specific readmissions, but in order to deliver specific initiatives to prevent 
readmissions, I believe that a disease-specific readmission-reduction predictive tool, 
especially in the case of stroke, would be most valuable.139 Although many prediction 
tools have been developed for identifying patients at higher risk of readmission 
regardless of the disease and the readmission cause, most of them lack validation.139 
Another strategy for reducing readmissions, especially in the vulnerable immediate 
post-discharge period, regards transitional care.240, 241 Transitional care refers to a set 
of actions developed to ensure the coordination and continuity of health care when a 
patient moves from one health care setting, for example a hospital, to another health 
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care setting, such as home or a nursing home.240, 242 Important care-transition 
strategies to reduce hospital readmissions include patient education, proper discharge 
planning, medication reconciliation, scheduling follow-up appointments, follow-up 
phone calls, and home visits.241 Such interventions proved useful in a quality 
improvement project on stroke patients, with a subsequent reduction of 30-day 
readmission rates from 9% to 3% and a reduction from 16% to 12% in emergency 
department visits.243 Urgent and unplanned transitions increase the risk of medication 
errors, inadequate communication between health care providers, and discharge to 
environments not capable of meeting the patients’ medical needs. A strategy to 
prepare patients for the life after discharge is the education of eligible patients about 
relevant diagnoses such as stroke risk factors and warning signs, prevention of 
infections, and attention towards fall-traps, and the importance of self-care and 
obtaining and taking prescribed medication and medication management.244 Another 
strategy is scheduling follow-up appointments with both primary care providers and 
outpatient neurological clinics. Hospitals often rely on quick follow-up by primary 
care providers for monitoring newly discharged patients, and the discharge 
paperwork often instructs the patient and primary care provider to schedule follow-up 
appointments. However, patients can be unable to schedule follow-up appointments 
quick enough, or there may be limited capacity in primary care. A retrospective 
cohort study including 78 345 elderly ischemic stroke patients discharged home 
found that early primary care visits or neurology visits led to a small, but significant, 
reduction in 30-day readmission.245 Furthermore, a clinical trial from Denmark with 
155 stroke patients discharged home with persistent disability and impairment, 
demonstrated significant reductions in six-month readmission rates for patients 
receiving follow-up home-visits by a physician or instructions from a physiotherapist 
compared to patients that received standard aftercare (26% and 34% versus 44%).246  
Readmissions are often unrelated to the initial admission as readmission may 
represent a progression in the natural history of underlying diseases and 
comorbidity.98 It is therefore important to remember that not all readmissions are 
preventable. Usually, readmissions are considered preventable if clinically related to 
a prior admission.247 Some studies have defined preventable readmissions as 
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readmissions related to predefined causes such as infections, COPD, hypertension, 
diabetes mellitus, heart failure, and dehydration,230, 231 whereas others have reviewed 
the medical records for determination of readmissions that could have been 
avoided.152, 248 Between 2% and 31% of all unplanned readmission within 30 days 
have been considered preventable.152, 230, 231, 248 However, the retrospective nature of 
these studies and the use of administrative data together with predefined categories of 
preventable causes limits the generalizability and impact of these studies. In relation 
to our findings, many of the most frequent causes of both short-term and long-term 
readmission may be potentially preventable, such as fractures, infections, and 
thromboembolism.  
A final aspect is the question on when to stop treating patients. Many stroke patients 
are old, multimorbid, fragile, and cognitive and physically impaired. Some of these 
patients may be better served by good palliative care rather than being readmitted for 
treatment at hospitals. It is not possible to give clear directions on scenarios where 
this applies, but good communication between patients, their families and the health 
care providers is essential, especially towards the end of life.  
Although readmission rates will never be zero, the current frequency of readmission 
includes many readmissions that could be prevented by improving care and initiate 
measures in patients at highest risk of readmission. Successful recovery after stroke 
requires that health care professionals also address other factors, such as comorbidity 
and care.150 Hospitals have limited control of care after discharge, so strategies to 
reduce readmission both in the acute and chronic phase must be multidisciplinary and 
involve health care professions in both secondary and primary care. All of the 
mentioned strategies to reduce readmission would be time-demanding in a system 
already under high pressure. Even though a minority of readmissions are preventable 
when reviewed retrospectively, intervention studies show promising results. If we 
could lower the readmission rates, it would release some of the pressure on the health 
care system, and be highly beneficial for the patients.  
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Strengths and limitations of the thesis 
Our studies have several limitations that deserve attention. All the included studies 
are registry-based, which thus can lead to either underestimation or overestimation of 
readmission rates after stroke. In our case, it is likely that we may have 
underestimated the readmission rates, because it is inevitable that some patients have 
been readmitted to hospitals outside the region of the Western Norway Regional 
Health Authorities. Our 30-day readmission rate largely resembles what has been 
found for 30-day readmission after stroke in the Western Norway Regional Health 
Authorities in the reports by the Norwegian Institute of Public Health, and we believe 
that few patients have been missed from our early-readmission rates.4 It is more likely 
that we have lost some readmissions happening beyond the first 30 days, which may 
have led to an underestimation of the long-term readmission rates. On the other side, 
we may also have overestimated the long-term incidences of readmission, as the 
Kaplan-Meier method is a survival model originally designed to investigate mortality 
over time. When the outcome of interest is different from all-cause death, such as in 
the case of readmission, mortality is a competing risk which can preclude the 
occurrence of readmission and lead to biased results.249 However, most studies 
investigating readmission with survival models have used Kaplan-Meier estimates 
and the Cox regression, easing the comparison between studies.  
A second limitation of using registry-based data is the lack of necessary information, 
which may result in confounding. The process of hospital readmission is 
multifactorial and may involve patient, family, health care system, and even 
environmental factors. It is inevitable that some factors in the process of readmission 
are not included in our study, for example medical compliance after discharge and 
long-term disability. Furthermore, medical records are not designed for research 
purposes, which may result in misclassified or unavailable data in some readmission 
cases.  
A third limitation lies in the TOAST classification, which has well-documented value 
but a high proportion of patients classified as stroke of undetermined cause.33, 35 
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Furthermore, the TOAST classification is not up to date on the recent technological 
advances, and many of the newer classification systems may be more appropriate in a 
clinical setting. However, the newer classifications depend on the availability of 
modern diagnostic technology, and some of them are not appropriate for research as 
there are too many subtypes.25  
A strength of our study is the ascertainment of data related to readmissions made by 
review of medical records, and the relatively large study population prospectively 
investigated according to a predefined protocol with a comprehensive collection of 
data. Although we cannot exclude that some individuals suffering ischemic stroke or 
TIA were not admitted to our hospital and thus not included in the NORSTROKE 
registry, the population-based design with the exclusion of patients living outside the 
local area of Haukeland University Hospital limits the influence of a selection bias. 
However, the generalizability of our studies is limited as a result of the single-
hospital design. Furthermore, all patients were treated in a stroke unit, which may 
lead to a better outcome and consequently lower readmission rates than studies 
including patients not treated in stroke units. Our cohort is small compared to many 
other studies investigating readmission, but most of these larger studies use 
administrative data for both identifying the cohort and readmissions, and many only 




We showed that the large majority of our ischemic stroke and TIA patients were 
readmitted within five years. More than one-third of our patients were readmitted 
within one year after discharge, with half of the readmissions occurring within the 
first 90 days. The top causes of readmission in both the acute and chronic phase were 
infections, stroke-related events, recurrent stroke or TIA, and cardiac disease. 
Fractures were another frequent cause of readmission in the chronic phase.  
We showed that most risk factors for readmission in the acute phase remained 
important long-term. These included increasing age, poorer functional outcome, atrial 
fibrillation, hypertension, and atherosclerosis in other sites than the cerebrovascular 
one. Patients readmitted early had more complications during the index admission 
and a poorer functional outcome than patients readmitted later after discharge. Our 
results indicate that rapid and good acute treatment in order to reduce stroke-related 
disability and proper cardiovascular risk factor management is important for reducing 
the burden of readmission after stroke. 
We showed that mortality and the rates and causes of readmission differed among 
stroke subtypes. The risk of 30-day readmission was highest in patients with LAA 
and SOE subtype, likely caused by an increased vulnerability of early recurrent stroke 
and stroke-related events. CE subtype was associated with the poorest long-term 
prognosis, with both the highest risk of readmission and death within five years. 
Stroke subtype may provide information that can be useful in a clinical setting for 
attention towards new diseases and readmission after discharge from the stroke units. 
We showed that readmission within 30 days after discharge was an independent risk 
factor for one-year mortality, and more than doubled the risk of dying within one year 
after ischemic stroke or TIA. Readmissions might thus have a mediating effect on 
stroke survival due to interference with functional recovery and poorer prognosis 
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Background. Stroke aetiologymay affect the risk and causes of readmission after ischaemic stroke (IS) and transient ischaemic attack
(TIA) due to differences in risk factors, functional outcome, and treatment. We aimed to examine frequencies, causes, and risk of
30-day readmission by stroke subtype, determine predictors of 30-day readmission, and study the impact of 30-day readmissions
on one-year mortality. Methods. All surviving patients admitted with IS or TIA from July 2007 to December 2013 were followed
by review of medical records for all unplanned readmissions within 30 days after discharge. Stroke subtype was classified as large-
artery atherosclerosis (LAA), cardioembolism (CE), small vessel occlusion (SVO), stroke of other determined aetiology (SOE),
or stroke of undetermined aetiology (SUE). Cox regression analyses were performed to assess the risk of 30-day readmission for
the stroke subtypes and identify predictors of 30-day readmission, and its impact on one-year mortality. Results. Of 1874 patients,
200 (10.7%) were readmitted within 30 days [LAA 42/244 (17.2%), CE 75/605 (12.4%), SVO 12/205 (5.9%), SOE 6/32 (18.8%), SUE
65/788 (8.3%)]. The most frequent causes of readmissions were stroke-related event, infection, recurrent stroke/ TIA, and cardiac
disease. After adjusting for age, sex, functional outcome, length of stay, and the risk factor burden, patients with LAA and SOE
subtype had significantly higher risks of readmission for any cause, recurrent stroke or TIA, and stroke-related events. Predictors
of 30-day readmission were higher age, peripheral arterial disease, enteral feeding, and LAA subtype. Thirty-day readmission was
an independent predictor of one-year mortality. Conclusions. Patients with LAA or SOE have a high risk of 30-day readmission,
possibly caused by an increased risk of recurrent stroke and stroke-related events. Awareness of the risk of readmission for different
causes and appropriate handling according to stroke subtype may be useful for preventing some readmissions after stroke.
1. Introduction
Stroke treatment has improved considerably over the last
decades, but 30-day readmission rates after stroke have
remained unchanged in Norway [1]. Thirty-day readmission
rates range from 6.0% to 15.0%, with infections, recur-
rent stroke, and cardiac conditions as leading causes [1–
8]. Reducing 30-day readmission is an important target in
reducing post-stroke morbidity, mortality, and health care
costs [9]. Many studies have attempted to identify predictors
of readmission after stroke as this might help detect high-risk
patients, but results across studies are inconsistent [2]. Factors
previously associatedwith 30-day readmission include higher
age, functional status, prior stroke or cardiac disease, longer
hospitalisation, and complications during stroke admission
[2–4].
Aetiologies causing ischaemic stroke (IS) and tran-
sient ischaemic attack (TIA) are categorised into different
stroke subtypes [10]. Cardiovascular risk factors, neurological
deficits, functional outcome, and early recurrence differ
between the subtypes [11–13]; therefore, stroke subtype may
influence the rates and causes of 30-day readmission. In
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lack of existing prediction models on the risk of 30-day
readmission after stroke, estimating the risk of readmission
for the different stroke subtypes might be a valuable approach
for detecting patients at higher risk of readmission. This
would also be easily accessible in a clinical setting. However,
the impact of stroke subtype on 30-day readmission risk is
not clear.
The aims of our study were to examine (1) frequency,
causes, and risk of 30-day readmission for the stroke sub-
types, (2) factors associated with unplanned readmission
within 30 days, and (3) the impact of 30-day readmission on
one-year mortality.
2. Methods
All patients with IS or TIA admitted to the Stroke Unit
at the Department of Neurology, Haukeland University
Hospital, from July 2007 to December 2013, were prospec-
tively registered in the Bergen NORSTROKE Registry. The
Stroke Unit serves a well-defined geographical area with
approximately 275,000 inhabitants. Patients with residence
outside the geographic area of the hospital at the time of
index hospitalisation were excluded from the study to ensure
complete follow-up after discharge.
IS was defined as an episode of neurologic deficit lasting
>24 hours because of ischaemic lesions or transient ischaemic
attacks where computed tomography or magnetic resonance
imaging showed infarctions related to the clinical findings
[14]. TIA was a clinical diagnosis defined as transient focal
cerebral dysfunction lasting < 24 hours with no objective
evidence of brain infarction on imaging. Electrocardiogram,
echocardiography, and duplex ultrasound of the carotid
arteries were obtained during hospital admission. Stroke
aetiology was classified by a stroke neurologist (HN) accord-
ing to the Trial of Org 10172 in Acute Stroke Treatment
(TOAST) criteria as large-artery atherosclerosis (LAA), car-
dioembolism (CE), small vessel occlusion (SVO), stroke of
other determined aetiology (SOE), or stroke of undetermined
aetiology (SUE) [10]. The National Institutes of Health
Stroke Scale (NIHSS) was used to assess stroke severity on
admission and day 7, or at discharge if earlier. Short-term
functional outcome was determined by modified Rankin
Scale (mRS) and Barthel Index (BI) on day 7 or at discharge
if earlier. Clinical characteristics, treatment, medical history,
comorbidity, complications, and the discharge destination
were registered before discharge from the Stroke Unit. The
number of traditional cardiovascular risk factors was defined
as the risk factor burden (0, 1, 2, or ≥ 3). These included
hypertension, diabetes mellitus, smoking, angina pectoris,
peripheral arterial disease, and prior myocardial infarction.
Secondary prevention from the day of discharge was based
on the Norwegian guidelines for stroke treatment [15].
Two clinicians (ATB & ANK) collected information
on readmission and death by reviewing electronic medical
records from all ten hospitals within the region of the
Western Norway Regional Health Authorities. Readmission
was defined as an unplanned admission to any department at
any of the hospitals within the region of the Western Norway
Regional Health Authorities. All unplanned readmissions
within 30 days after discharge were registered and divided
into predefined categories (any cause, recurrent stroke,
stroke-related event, seizure, infection, cardiac disease, frac-
ture, venous thromboembolism, gastrointestinal haemor-
rhage, and other cause). Only the first readmission within
each category was registered for each patient. Patients who
died during index hospitalisation and patients discharged to
palliative care were excluded from the analyses.
The study was approved by the Western Regional Ethics
Committee, andwritten informed consent was obtained from
all patients or their legal guardian.
Statistical analyses were performed using Stata 14.0 (Stata
Corporation, College Station, TX, USA). Baseline charac-
teristics were assessed by chi-squared test, Student’s t-test,
Mann–Whitney’s U-test, or Kruskal-Wallis H-test as appro-
priate.The risks of readmission for any cause and for themost
common categories of readmission were assessed by Cox
regression analyses for each subtype compared to patients
with other stroke subtypes. In addition to the stroke subtype,
all analyses included age, sex, mRS score, length of stay, and
the risk factor burden to adjust for potential confounding
factors. Predictors of the 30-day readmission were assessed
by Cox regression with stepwise backward elimination of all
significant parameters (P<.05) from the univariate analyses.
Age, sex, mRS score, and length of stay were forced into
the multivariate analyses to adjust for potential confounding
factors. The impact of 30-day readmission on one-year
mortality was studied by Cox regression analyses adjusted
for age, sex, mRS score, and risk factors for cerebrovascular
disease and death, after excluding patients who died within
30 days after discharge.
3. Results
A total of 1989 patients were admitted to the stroke unit and
diagnosedwith IS (89.6%) or TIA (10.4%), of whom 101 (5.1%)
died in the stroke unit, and 14 (0.7%) were discharged to
palliative care. The final study population consisted of 1874
patients, of whom 200 (10.7%) were readmitted within 30
days (10.9% of IS patients, 9.2% of TIA patients, p = 0.475).
The distribution of readmissions among the stroke subtypes
was as follows: LAA 42/244 (17.2%), CE 75/605 (12.4%), SVO
12/205 (5.9%), SOE 6/32 (18.8%), and SUE 65/788 (8.3%).
Nineteen patients had two unplanned readmissions within
30 days, and two patients had three unplanned readmissions
within 30 days. Median time to first unplanned readmission
was 11 days (IQR 5-19).
Baseline characteristics of the study population by 30-
day readmission status are presented in Table 1. Patients who
were readmitted within 30 days were in general older, had
a poorer short-term functional outcome (higher mRS score
and lower BI score), and a higher NIHSS score at discharge
than patients not readmitted within 30 days. Readmitted
patients also had more cardiovascular comorbidity and a
higher risk factor burden, and more frequently experienced
complications during the index hospitalisation than patients
not readmitted within 30 days. Patients with LAA subtype
weremore likely to be readmitted, whereas patients with SVO
or SUE subtype were less likely to be readmitted.
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N = 1674 P
Age (years), mean ± SD 77.2 ± 11.8 72.8 ± 13.7 <0.001
Male sex 105 (52.5) 931 (55.6) 0.402
Stroke severity and functional outcome
mRS score at discharge, median (IQR) 2 (1, 4) 2 (1, 3) <0.001
NIHSS score at discharge, median (IQR) 3 (1, 8) 1 (0, 4) <0.001
BI score at discharge, median (IQR) 90 (40, 100) 100 (75, 100) <0.001
Stroke subtype
Atherosclerosis 42 (21.0) 202 (12.1) <0.001
Cardioembolism 75 (37.5) 530 (31.7) 0.095
Small vessel occlusion 12 (6.0) 193 (11.5) 0.018
Other determined aetiology 6 (3.0) 26 (1.6) 0.136
Undetermined aetiology 65 (32.5) 723 (43.2) 0.004
Comorbidities
Prior stroke 49 (24.5) 324 (19.4) 0.085
Peripheral arterial disease 26 (13.0) 110 (6.6) 0.001
Diabetes 39 (19.5) 244 (14.6) 0.066
Angina pectoris 40 (20.0) 220 (13.1) 0.008
Myocardial infarction 35 (17.5) 235 (14.0) 0.188
Hypertension 133 (66.5) 922 (55.1) 0.002
Atrial fibrillation 70 (35.0) 475 (28.4) 0.051
Prior/current smoking 122 (61.0) 965 (57.7) 0.364
Risk factor burden 0.007
0 44 (22.0) 463 (27.7)
1 66 (33.0) 643 (38.4)
2 53 (26.5) 377 (22.5)
≥3 37 (18.5) 191 (11.4)
Treatment
Intravenous thrombolysis 33 (16.5) 274 (16.4) 0.962
Thrombectomy 6 (3.0) 22 (1.3) 0.063
Complications during the stroke hospitalisation
Urinary tract infection 38 (19.0) 187 (11.2) 0.001
Incontinence 31 (15.5) 211 (12.6) 0.248
Urinary retention 55 (27.5) 325 (19.4) 0.007
Pneumonia 24 (12.0) 105 (6.3) 0.002
Enteral feeding 29 (14.5) 106 (6.3) <0.001
Seizures 9 (4.5) 36 (2.2) 0.040
Stroke in progression 23 (11.5) 147 (8.8) 0.206
Any complication 100 (50.0) 637 (38.1) 0.001
Length of stay, median (IQR) 6 (3, 11) 6 (3, 10) 0.553
Discharged destination
Home 77 (38.5) 928 (56.0) <0.001
Home nursing 28 (14.0) 166 (10.0) 0.081
Rehabilitation department 10 (5.0) 141 (8.5) 0.087
Nursing home 69 (34.5) 376 (22.7) <0.001
Other department 16 (8.0) 47 (2.8) <0.001
SD: standard deviation, mRS: modified Rankin Scale, IQR: interquartile range, NIHSS: National Institutes of Health Stroke Scale, BI: Barthel Index.
Data are expressed as n (%) unless specified.
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Table 2: Causes of unplanned readmissions within 30 days after IS or TIA by stroke subtype.











Any cause 200 (10.7) 42 (17.2) 75 (12.4) 12 (5.9) 6 (18.8) 65 (8.3) <0.001
Recurrent stroke 34 (1.8) 11 (4.5) 8 (1.3) 1 (0.5) 3 (9.4) 11 (1.4) <0.001
IS 26 (1.4) 6 (2.5) 7 (1.2) 1 (0.5) 3 (9.4) 9 (1.1) 0.001
TIA 4 (0.2) 4 (1.6) 0 0 0 0 <0.001
ICH 4 (0.2) 1 (0.4) 1 (0.2) 0 0 2 (0.3) 0.898
Stroke-related event 51 (2.7) 16 (6.6) 11 (1.8) 4 (2.0) 3 (9.4) 17 (2.2) <0.001
Seizures 5 (0.3) 0 3 (0.5) 0 0 2 (0.3) 0.647
Infections 37 (2.0) 7 (2.9) 13 (2.2) 4 (2.0) 0 13 (1.7) 0.703
Pneumonia 19 (1.0) 3 (1.2) 6 (1.0) 3 (1.5) 0 7 (0.9) 0.913
UTI 9 (0.5) 1 (0.4) 4 (0.7) 0 0 4 (0.5) 0.810
Sepsis 5 (0.3) 2 (0.8) 1 (0.2) 1 (0.5) 0 1 (0.1) 0.395
Other 4 (0.2) 1 (0.4) 2 (0.3) 0 0 1 (0.1) 0.806
Cardiac disease 26 (1.4) 1 (0.4) 17 (2.8) 0 0 8 (1.0) 0.005
MI 6 (0.3) 0 1 (0.2) 0 0 5 (0.6) 0.350
Arrhythmias 5 (0.3) 1 (0.4) 4 (0.7) 0 0 0 0.167
Other 16 (0.9) 0 13 (2.2) 0 0 3 (0.4) 0.001
Fractures 7 (0.4) 0 5 (0.8) 0 0 2 (0.3) 0.244
VT 3 (0.2) 1 (0.4) 1 (0.2) 0 0 1 (0.1) 0.846
GI bleeding 4 (0.2) 0 2 (0.3) 1 (0.5) 0 1 (0.1) 0.739
Other causes 49 (2.6) 13 (5.3) 20 (3.3) 3 (1.5) 0 13 (1.7) 0.011
IS: ischaemic stroke, TIA: transient ischaemic attack, LAA: large artery atherosclerosis, CE: cardioembolism, SVO: small vessel occlusion, SOE: stroke of other
determined aetiology, SUE: stroke of undetermined aetiology, ICH: intracerebral haemorrhage, UTI: urinary tract infection, MI: myocardial infarction, VT:
venous thromboembolism, GI: gastrointestinal.
Data are presented as n (%). Only the first readmission within each category is counted.











Age (years), median (IQR) 75 (66, 82) 79 (68, 86) 69 (60, 80) 47 (38, 56) 74 (64, 83) <0.001
Male sex, N (%) 159 (65.2) 318 (52.6) 123 (60.0) 21 (65.6) 415 (52.7) 0.002
mRS score, median (IQR) 2 (0, 3) 2 (1, 4) 2 (1, 3) 1 (0, 2) 1 (0, 3) <0.001
Length of stay (days) 5 (3, 9) 6 (3, 10) 6 (3, 10) 8 (5, 12) 6 (3, 9) 0.029
Risk factor burden, N (%) <0.001
0 34 (13.9) 168 (27.8) 55 (26.8) 15 (46.9) 235 (29.8)
1 83 (34.0) 234 (38.7) 86 (42.0) 17 (53.1) 289 (36.7)
2 70 (28.7) 142 (23.5) 42 (20.5) 0 (0.0) 176 (22.3)
≥3 57 (23.4) 61 (10.1) 22 (10.7) 0 (0.0) 88 (11.2)
IQR: interquartile range, mRS: modified Rankin Scale.
The most frequent cause of readmission was stroke-
related events: 10 with evolving strokes (NIHSS score wors-
ening ≤ 4 points from NIHSS score at discharge with
symptoms from the same vascular territory as the index
stroke), 19 with aggravation of existing neurological deficits
(neurological symptomsnotmeasurable by theNIHSS score),
2 with haemorrhagic transformation, 3 with neurological
complications after carotid endarterectomy, 1 with extracra-
nial haemorrhage, 1 with carotid dissection, and 15 with other
neurological symptoms. The length of index hospitalisation
was slightly shorter for patients that were readmitted with
a stroke-related event compared to patients that were not
readmitted with a stroke-related event (median 5 days (IQR
5-8) versus median 6 days (IQR 3-10), p=0.193). Infection
was the second most frequent cause of readmission, followed
by recurrent stroke or TIA, and cardiac disease. The causes
of readmission were unevenly distributed among the stroke
subtypes (Table 2).
Table 3 shows the distribution of age, sex, mRS score,
length of stay, and the risk factor burden among the stroke
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Table 4: Factors Associated with 30-day Unplanned Readmission
after IS or TIA.
Hazard
Ratio 95% Confidence Interval P
Age (years) 1.020 1.006 – 1.034 0.004
Sex (male) 0.936 0.690 – 1.268 0.667
mRS score 0.990 0.894 – 1.095 0.842
Length of stay (days) 0.997 0.973 – 1.022 0.846
Peripheral arterial
disease 1.577 1.007 – 2.468 0.047
LAA subtype 1.735 1.201 – 2.505 0.003
Enteral feeding 1.861 1.112 – 3.114 0.018
IS: ischaemic stroke, TIA: transient ischaemic attack, mRS: modified Rankin
Scale, LAA: large artery atherosclerosis.
subtypes. After adjusting for these factors, patients with
stroke due to LAA had an increased risk of readmission for
any cause (HR=1.76, 95%CI 1.22-2.53, p=0.002), readmission
with recurrent stroke or TIA (HR = 3.31, 95% CI 1.55-
7.07, p=0.002), and readmission with stroke-related events
(HR=2.98, 95%CI 1.55-5.74, p=0.001). Patients with SOE had
an increased risk of readmission for any cause (HR=2.81,
95% CI 1.11-7.10, p=0.029), recurrent stroke (HR=6.00, 95%
CI 1.26-28.57, p=0.024), and stroke-related events (HR=4.27,
95% CI 1.19-15.35, p=0.026). The recurrent strokes in the
SOE group were ascribed to dissection of the middle cere-
bral artery, giant cerebral aneurysm, and pancreatic cancer,
respectively. Patients with SUE had a lower risk of readmis-
sion for any cause compared to other subtypes (HR=0.71,
95% CI 0.52-0.97, p=0.031). Patients with CE subtype had
an increased risk of readmission due to cardiac disease
(HR=2.56, 95% CI 1.07-6.09, p=0.034). Exclusion of SOE
from the regression models did not alter any findings.
Factors independently associated with 30-day readmis-
sion from the final Cox regression model were increasing
age, history of peripheral arterial disease, enteral feeding dur-
ing index hospitalisation (nasogastric tube or percutaneous
endoscopic gastrostomy), and LAA subtype (Table 4).
Within 30 days, 61 (3.3%) patients died, of whom 29
(47.5%) had been readmitted. There were no significant dif-
ferences in 30-day mortality between stroke subtypes (LAA
3.3%, CE 4.1%, SVO 1%, SOE 0%, and SUE 3.3%, p = 0.203).
Within one year, 139 (7.4%) additional patients died, of whom
36 (25.9%) had been readmitted within 30 days. One-year
mortality significantly differed between the stroke subtypes
(LAA 11.8%, CE 14.0%, SVO 3.4%, SOE 3.1%, and SUE 10.2%,
p = 0.001).Thirty-day readmission significantly increased the
risk of one-year mortality in patients surviving 30 days after
discharge after adjusting for age, sex, mRS score, and risk
factors for cerebrovascular disease and death (HR 2.57, 95%
CI 1.75 – 3.78, p < 0.001).
4. Discussion
This is one of the first and the current largest studies inves-
tigating the impact of stroke subtype on 30-day readmission
after ischaemic stroke or TIA. Our study demonstrates that
30-day readmission varies depending on the stroke subtype,
ranging from 5.9% for patients with SVO to 17.2% for
patients with LAA and 18.8% for patients with SOE. A study
performed in a younger stroke population found that 14%
of patients with thrombotic strokes were readmitted within
30 days, whereas 22% of patients with CE strokes were
readmitted within 30 days [16]. Another study found that
22% of patients with CE and 20% of patients with LAA
subtypewere readmittedwithin 30 days, whereas SUEhad the
lowest rate of readmission, with 8% readmittedwithin 30 days
[4]. These discrepancies are likely due to study populations
with different demography, lower mean ages, and different
distribution of stroke subtypes than ours.
The varying readmission rates between the stroke sub-
types could be caused by differences in age, functional
outcome, and risk factors. After adjusting for these factors,
patients with SVO, which had the lowest number of read-
mission, did not have a lower risk of readmission compared
to other subtypes. However, the risk of 30-day readmission
was significantly increased in patients with LAA and SOE
subtype, whereas patients with SUE had a significantly lower
risk of readmission after adjusting for confounders.
Two of the most common causes of readmission were
stroke-related events and recurrent stroke. The risk of recur-
rent stroke is highest in the early phase after the initial
IS or TIA [11]. Awareness and attention towards recurrent
strokes and a low threshold for readmission in cases which
could represent recurrent strokes, may contribute to a high
rate of readmissions with stroke-related events such as
aggravation or fluctuation of existing neurologic symptoms.
Thus, education of patients and their families in the natural
course of the post-stroke period may reduce some of these
readmissions.
In concordance with recent studies on 30-day recurrence,
only 1.8 % were readmitted with a recurrent stroke within
30 days [17, 18]. However, 4.5% of patients with LAA
subtype were readmitted with recurrent stroke within 30
days. LAA subtype has previously been associated with early
recurrent stroke [11, 12]. This could be caused by repetitive
shedding of thrombi from unstable atherosclerotic plaques
triggered by shear stress [19], or cerebral ischaemia induced
by carotid surgery in some patients, but the reason for the
high risk of early recurrence in patients with LAA is not
yet fully understood. Patients with LAA or SOE subtype
had increased risks of recurrent stroke and stroke-related
events, which likely explains their overall increased risk of
30-day readmission. LAA subtype was also an independent
predictor of 30-day readmission, probably due to increased
recurrence of recurrent stroke or TIA and aggravation of
neurological symptoms. Few studies have reported stroke
recurrence for patients with SOE as a result of low numbers
of subjects. The increased risk of recurrence as well as
readmission for any cause and stroke-related events for
patients with SOE in our study could be a chance finding
due to a low number of subjects and should be interpreted
with caution. However, it is possible that SOE includes
some rare aetiologies with an especially high risk of early
recurrence.
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Infection was a frequent complication during index hos-
pitalisation in our study, and the second most common cause
of readmission. Early infections after stroke are associated
with enteral feeding whichmight explain why enteral feeding
independently increased the risk of 30-day readmission [20].
Poor functional outcome has also been associated with post-
stroke infections [21]. Even though there were differences in
short-term functional outcome between the stroke subtypes,
the median mRS score was 2 or less for all stroke subtypes.
This might explain why we found no differences in infection-
related readmission between the stroke subtypes. Poor func-
tional outcome and length of stay have been associated with
early readmission [2, 3]. This could be due to an increased
risk of infection in patients with poor functional outcome
as well as a higher risk of undetected medical complications
if patients are discharged too early [21]. The present study
unexpectedly found that poor functional outcome and length
of stay were not associated with readmission. This could
be due to higher rates of cardiovascular and stroke-related
readmissions than infections, which, in contrast to infections,
likely are not affected by functional outcome or length of
stay to the same extent. This might also explain why we
found no differences in readmission between IS and TIA
patients.
Thirty-day readmission was significantly associated with
an increased risk of one-year mortality. This has previ-
ously been demonstrated [9] and could perhaps be due
to interference with functional recovery after stroke if
the patient is readmitted. Also, the cause of readmission
might contribute to a worse prognosis and higher post-
stroke mortality, as demonstrated for post-stroke pneumonia
and recurrent stroke [22, 23]. Even though most readmis-
sions are unavoidable when reviewed retrospectively [24],
a reduction in readmission rates have been demonstrated
with early outpatient visits by physicians, and with edu-
cation of patients about relevant diagnoses, and confir-
mation of the medication plan [25–27]. Sufficient moni-
toring and care for prevention of medical complications,
both during hospitalisation and in the immediate post-
hospital care setting, may be key factors in preventing
some readmissions. In addition, a thorough evaluation for
detecting the underlying cause of the stroke and awareness
of readmission risk and treatment according to the stroke
subtype may be useful in preventing some readmissions after
stroke.
A weakness of the present study is the lack of information
in the few cases where patients were transferred to other
hospital departments. It is unlikely that we have missed some
readmissions, as we exclusively included patients served by
our hospital and obtained data on readmissions from all ten
hospitals in our region. Our study is unable to demonstrate
a direct, causative relationship between stroke subtype and
readmissions as it was an observational study. The study-
design limits the generalisability due to possible selection
bias, but it provides precise and verified clinical data with the
use of a comprehensive registry and medical record review,
contributing to a better understanding of underlying causes
of the readmissions.
5. Conclusions
Readmission within 30 days after IS and TIA remains fre-
quent in Norway. The risk and causes of 30-day readmission
differed between the stroke subtypes and were especially
high in patients with LAA and SOE. Stroke subtype may
substitute as a 30-day readmission risk estimator in lack of
more precise risk-estimation models, but more studies are
needed to confirm our findings.
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Causes and Predictors for Hospital Readmission after
Ischemic Stroke
Anna T. Bjerkreim, MS,*† Lars Thomassen, MD, PhD,*† Jan Brøgger, MD, PhD,†
Ulrike Waje-Andreassen, MD, PhD,† and Halvor Næss, MD, PhD*†‡
Background: Readmission after stroke is frequent, but limited data are available in
Europe. This study aimed at assessing frequencies, causes, and factors associated
with early and late unplanned readmissions within 1 year after discharge from
ischemic stroke hospitalization. Methods: All surviving ischemic stroke patients
admitted to the Department of Neurology, HaukelandUniversity Hospital, Norway,
between July 1, 2007, and June 30, 2012, were followed from discharge until August
1, 2012. Information on readmissions was collected by medical chart reviews. Logis-
tic regression was performed to assess factors associated with early (#90 days) and
late (91-365 days) readmission. Results: Of 1175 patients discharged alive, 18.8%
were readmitted within 90 days, and 24.5% were readmitted between day 91 and
365. Most frequent causes were infections, recurrent ischemic stroke, other cardio-
vascular events, and events related to index stroke. Early readmission was associ-
ated with older age, impaired physical function, atherosclerotic etiology of index
stroke, and a higher risk factor burden. Late readmission was associated with older
age and prior myocardial infarction. Early readmitted patients had shorter length of
index admission, poorer physical function and higher frequencies of atherosclerotic
etiology of index stroke, atrial fibrillation, and complications with infection during
the index admission compared to patients readmitted late. Conclusions:
Readmission after ischemic stroke is frequent, especially in the early period after
discharge. Diagnoses and predictors varied according to time point for readmission,
reflecting different underlying mechanisms for causes of readmission. Causes
of early readmission may include a prothrombotic state and disposition for recur-
rent infections. Key Words: Readmission—rehospitalization—stroke—ischemic
stroke—outcome research.
 2015 by National Stroke Association
Conditions leading to readmission of stroke survivors
cause greater disability for the patient, increased mortal-
ity, and higher costs for the society.1,2 However, limited
data are available regarding the burden on readmission
after stroke, especially in Europe.
Within 1 year after discharge, 31%-49% of stroke survi-
vors experience readmissions,3-6 and nearly half of the
first readmissions occur within 90 days.6 Leading causes
of readmission are infections, recurrent cerebrovascular
events, and other cardiovascular diseases.5-7
Predictors of readmission after stroke might help
prevent some of the complications and readmissions. Pre-
viously reported factors associated with readmission
have been older age, impaired physical function,6,8-10
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increased length of index admission for stroke,3,6,10
complication during index admission,6,11 and comor-
bidities such as diabetes mellitus, prior stroke, coronary
artery disease, and atrial fibrillation.6 Despite many
attempts, there are no standardized models for predicting
risk of readmission after stroke.12
The aims of this hospital-based cohort study were to (1)
estimate frequencies of unplanned readmissions after
discharge from ischemic stroke hospitalization, (2) deter-
mine the causes for readmission, and (3) investigate fac-
tors associated with readmission.
We hypothesized that the risk of readmission was high
during the first 90 days after discharge, because some
patients may be in a prothrombotic state, experience
delayed hospital-acquired infections, or be prone to infec-
tions after ischemic stroke. We therefore investigated
early (#90 days) and late (91-365 days) readmissions
separately.
Materials and Methods
All patients with acute ischemic stroke admitted to the
Department of Neurology at Haukeland University
Hospital between July 1, 2007, and June 30, 2012, were
prospectively registered in the Bergen NORSTROKE
Registry. The stroke unit serves a well-defined region of
approximately 250,000 people. We obtained written
informed consent from all patients. This study includes
patients living in the local area of Haukeland University
Hospital. Patients who died during index admission
were excluded from the study.
Ischemic stroke was defined as a neurologic deficit last-
ing more than 24 hours or a clinically transient ischemic
attack where computed tomography or magnetic reso-
nance imaging showed infarctions related to the initial
clinical symptoms.13 The National Institutes of Health
Stroke Scale (NIHSS) score was used to assess stroke
severity on admission and day 7. Short-term outcome
was determined bymodified Rankin Scale (mRS) and Bar-
thel Index on day 7 (or at discharge if discharged earlier
than 7 days). Electrocardiogram and duplex ultrasound
of the carotid arteries were obtained. Stroke etiology
was classified by the Trial of Org 10172 in Acute Stroke
Treatment (TOAST) criteria.14 Clinical characteristics,
medical history, and stroke cause were registered by a
neurologist within 1 day after admission. The risk factor
burden was defined by traditional risk factors as 0, 1, 2,
and 3 or more risk factors. These included hypertension,
diabetes mellitus, smoking, angina pectoris, peripheral
vascular disease, and prior myocardial infarction. Other
risk factors registered were prior cerebrovascular disease,
atrial fibrillation, and prior coronary intervention. Com-
plications during the index admission included urinary
incontinence, urinary retention, urinary tract infection
(UTI), pneumonia, seizures, and stroke in progression
(NIHSS score worsening $4 points during the first
week after stroke onset compared to NIHSS score on
admission). Secondary preventive treatment on discharge
was based on the Norwegian guidelines for stroke treat-
ment.15
Information regarding hospital readmissions after
discharge from the index stroke until August 1, 2012,
was collected by medical chart reviews. Outcome was
defined as the first unplanned readmission. Subjects
were dichotomized during follow-up as readmitted or
not readmitted. When investigating frequencies, causes,
and predictors of readmission, readmitted patients were
divided into 2 groups: readmission# 90 days (early read-
mission) and readmission 91-365 days (late readmission).
Patients who could not be followed for the respective time
intervals, and patients who were either dead or had been
readmitted before the 91-365 days interval, were excluded
from the respective intervals. Possible hospital-acquired
infections were assessed by comparing the proportion
of readmission with infections the first 30 days after
discharge to day 31-60. A possible prothrombotic state
was assessed by comparing the proportion of readmis-
sions with recurrent ischemic stroke or myocardial infarc-
tion # 90 to day 91-180.
The study was approved by the Western Regional
Ethics Committee (REC).
Statistics
Proportions were used to describe frequencies and
causes of readmission. Student t test, chi-square test,
and Mann–Whitney U test were used to investigate base-
line characteristics. Logistic regression analyses were per-
formed to identify factors independently associated with
early and late readmission. Analyses were performed by
stepwise backward elimination where first step included
all parameters that turned out significant (P , .05) in the
univariate analyses. Age, sex, and mRS were forced into
each regression to adjust for potentially confounding fac-
tors. Kaplan–Meier was performed to illustrate readmis-
sion and survival based on etiology. Statistical analyses
were performed with Stata 12.0 (Stata Corporation, Col-
lege Station, TX, USA).
Results
A total of 1250 patients were admitted with acute
ischemic stroke between July 1, 2007, and June 30, 2012.
During the index admission, 75 (6.0%) patients died.
Thus, 1175 patients were discharged alive and included
in the study.
Frequencies and Causes of First Unplanned
Readmission
Frequencies and causes of first unplanned readmission
are presented in Table 1. Of all patients who could be fol-
lowed for 1 year after discharge (n5 943), 355 (37.7%) had
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at least 1 unplanned readmission during the first year.
Most frequent causes for readmission were infections,
recurrent ischemic stroke, other cardiovascular diseases,
and events related to index stroke (stroke in progression,
subarachnoid hemorrhage, subdural hemorrhage, and
readmissions with presumed recurrent stroke where
this was disproved).
More patients were readmitted with recurrent ischemic
stroke or acute myocardial infarction #90 days (n 5 34)
than during day 91-180 (n 5 12) after discharge
(P 5 .02). Patients with pneumonia during index admis-
sion had significantly higher frequencies of readmission
with pneumonia both #90 days and 91-365 days. The
associations were also significant when adjusting for
age, sex, and the severity of the stroke (#90 days: odds
ratio [OR] 5 7.0, P , .001; 91-365 days: OR 5 5.2,
P 5 .015). Patients with UTI during index admission
had higher frequencies of readmission for UTI both
#90 days and 91-365 days (both P , .01). Patients with
urinary retention during index admission had higher fre-
quencies of readmission with UTI #90 days (P , .01).
When adjusting for age, sex, and the severity of the stroke,
readmission with UTI #90 days was significantly associ-
ated with UTI (OR 5 5.8, P 5 .031) or urinary retention
(OR 5 10.2, P 5 .041) during index admission. More
patients were readmitted with infections the first
30 days (n 5 22) compared to day 31-60 (n 5 6) after
discharge (P 5 .01).
Factors Associated with First Unplanned Readmission
Early Readmission (#90 days)
Baseline characteristics of patients readmitted early
are presented in Table 2. More patients discharged to
home nursing or nursing homes were readmitted early
compared to patients discharged home (n 5 115 [27%]
versus n 5 71 [12%], P , .001). Patients readmitted early
had higher frequencies of atherosclerotic etiology of index
stroke (n 5 37 [17%], P # .001) and cardioembolic stroke
(n 5 90 [42%] P 5 .023), and lower frequencies of stroke
due to small-vessel disease (n 5 14 [7%], P 5 .003). As
to the locations of index ischemic stroke, only watershed
infarct was associated with early readmission (n 5 14
[44%], P , .001). Nine (60%) of these patients were read-
mitted with recurrent ischemic stroke or events related
to the index stroke. Early readmission was not associated
with length of index admission. Logistic regression
showed an association between early readmission and
older age, higher mRS score, atherosclerotic etiology of in-
dex stroke, atrial fibrillation, and the risk factor burden
(Table 3).
Late Readmission (91-365 days)
Baseline characteristics of patients readmitted late are
presented in Table 2. Patients readmitted late were more
often discharged to home nursing or nursing homes
compared to discharged home (n 5 69 [30%] versus
n 5 83 [20%], P 5 .005). Logistic regression showed an
association between late readmission, higher age, and
prior myocardial infarction, and an inverse association
with small-vessel disease stroke. Higher mRS score was
not associated with late readmission (Table 4).
Early versus Late Readmitted Patients
Logistic regression with early versus late readmission
as dependent variable showed that early readmitted
patients had higher mRS score, shorter length of index
admission, and higher frequencies of atherosclerotic etiol-
ogy of index stroke, atrial fibrillation, and complications
with pneumonia or UTI than patients who were readmit-
ted late (Table 5). Figure 1 illustrates readmission over
time grouped by the TOAST classification.
Discussion
This is the first study to investigate the burden of
readmission after ischemic stroke in Norway. More










Cardiovascular disease 28 (2.4) 19 (2.5)
Myocardial infarction 9 (.8) 6 (.8)
Angina 4 (.3) 3 (.4)
Other heart disease 15 (1.3) 10 (1.3)
DVT/pulmonary embolism 2 (.2) 1 (.1)
Cerebrovascular disease 28 (2.4) 29 (3.9)
Ischemic stroke 25 (2.2) 24 (3.2)
Hemorrhagic stroke 1 (.1) 2 (.3)
TIA 2 (.2) 3 (.4)
Events related to index
stroke*
34 (2.9) 20 (2.7)
Seizure 8 (.7) 6 (.8)
Fracture 11 (.9) 13 (1.7)
Hip fracture 7 (.6) 5 (.7)
Other fracture 4 (.3) 8 (1.1)
Infection 36 (3.1) 38 (5.1)
Pneumonia 21 (1.8) 14 (1.9)
Urinary tract infection 7 (.6) 7 (.9)
Other infection 8 (.7) 17 (2.3)
Ulcers/GIT bleeding 9 (.8) 3 (.4)
Warfarin complication 3 (.3) 1 (.1)
Other causes 59 (5.1) 53 (7.1)
Readmitted patients, total 218 (18.8) 183 (24.5)
All patients 1162 (100) 747 (100)
Abbreviations: DVT, deep vein thrombosis; GIT, gastrointestinal;
TIA, transient ischemic attack.
*Question of stroke, stroke in progression, extracerebral
hemorrhage.
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than one-third of our patients experienced at least 1
unplanned readmission within a year after discharge.
This is comparable to studies from other countries where
1-year readmission varied from 37% to 40%.5,10,16 A
hospital-based study from Taiwan reported a lower
1-year readmission frequency of 31%,6 which may be
because of lower mean age than in our study. Nearly
half of all unplanned readmissions in the present study
occurred within 90 days after discharge, which has also
been reported previously.6,7
Infection was the most common cause of readmission.
When investigating this further, we found that
pneumonia, UTIs, or urinary retention during the index
admission was associated with readmission because of
Table 2. Baseline characteristics of patients readmitted early (#90 days) and late (91-365 days)
Chararteristics
Early readmission #90 days Late readmission 91-365 days
Readmitted Not readmitted P Readmitted Not readmitted P
Total 218 (18.8) 944 (81.2) 183 (24.5) 564 (75.5)
Males 112 (51.4) 517 (54.8) .37 106 (57.9) 308 (54.6) .43
Age (y) mean 6 SD 77.2 6 11.5 72.4 6 13.7 ,.01 75.1 6 12.5 71.1 6 13.8 ,.01
mRS score, median (IQR) 3 (1, 4) 2 (1, 3) ,.01 2 (1, 4) 2 (1, 3) .03
NIHSS score, median (IQR) 4 (2, 9) 3 (1, 6) ,.01 4 (1, 7) 3 (1, 6) .04
BI score, median (IQR) 90 (45, 100) 100 (70, 100) ,.01 100 (65, 100) 100 (80, 100) .01
Prior comorbidity
Cerebrovascular disease 53 (24.9) 176 (18.9) .05 46 (25.1) 104 (18.5) .05
Peripheral vascular disease 23 (10.6) 62 (6.6) .04 16 (8.7) 38 (6.7) .36
Diabetes 42 (19.4) 131 (14.0) .04 32 (17.6) 73 (13.0) .12
Angina pectoris 44 (20.3) 119 (12.6) ,.01 29 (15.9) 62 (11.0) .08
Myocardial infarction 40 (18.4) 129 (13.7) .08 36 (19.7) 58 (10.3) ,.01
Coronary intervention 27 (12.5) 119 (12.6) .95 30 (16.5) 55 (9.8) .01
Hypertension 141 (64.7) 512 (54.2) ,.01 107 (58.5) 294 (52.1) .14
Atrial fibrillation 93 (42.7) 274 (29.0) ,.01 61 (33.3) 145 (25.7) .045
Prior/current smoking 42 (30.9) 218 (42.0) .02 30 (29.1) 141 (45.6) ,.01
Risk factor burden ,.01 .07
0 37 (17.7) 224 (24.8) 45 (25.6) 142 (26.1)
1 68 (32.5) 374 (41.5) 62 (35.2) 236 (43.5)
2 71 (34.0) 197 (21.8) 39 (22.2) 107 (19.7)
$3 33 (15.8) 107 (11.9) 30 (17.0) 58 (10.7)
IS etiology ,.01 .08
Atherosclerosis 37 (17.1) 98 (10.4) 18 (9.9) 62 (11.0)
Cardioembolism 90 (41.5) 313 (33.3) 69 (38.1) 170 (30.2)
Small-vessel disease 14 (6.4) 129 (13.7) 16 (8.8) 90 (16.0)
Other determined 5 (2.3) 12 (1.3) 1 (.6) 7 (1.2)
Undetermined 71 (32.7) 389 (41.4) 77 (42.5) 234 (41.6)
Complications
Urinary tract infection 46 (21.1) 121 (12.8) ,.01 22 (12.0) 68 (12.1) .99
Incontinence 45 (20.6) 148 (15.7) .08 38 (20.8) 70 (12.4) ,.01
Urinary retention 72 (33.0) 231 (24.5) ,.01 54 (29.5) 125 (22.2) .04
Pneumonia 30 (13.8) 72 (7.6) ,.01 12 (6.6) 30 (5.3) .53
Seizures 9 (4.1) 22 (2.3) .14 5 (2.7) 14 (2.5) .85
Stroke in progression 34 (21.7) 98 (14.3) .02 18 (14.4) 58 (14.0) .91
Length of index admission,
median (IQR)
7 (4, 12) 7 (4, 11) .46 7 (4, 12) 7 (4, 11) .17
Discharged to ,.01 ,.01
Home 71 (32.6) 504 (53.4) 83 (45.4) 331 (58.7)
Home nursing 43 (19.7) 113 (12.0) 30 (16.4) 58 (10.3)
Rehabilitation 15 (6.9) 87 (9.2) 16 (8.7) 55 (9.8)
Nursing home 72 (33.0) 201 (21.3) 39 (21.3) 105 (18.6)
Other department 17 (7.8) 39 (4.1) 15 (8.2) 15 (2.7)
Abbreviations: BI, Barthel Index; IQR, interquartile range; IS, ischemic stroke; mRS, modified Rankin Scale; NIHSS, National Institutes of
Health Stroke Scale; SD, standard deviation.
Data are expressed as n (%) unless specified.
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pneumonia or UTIs respectively. An explanation may be
that some patients are prone to recurrent infections even
when treated adequately, because of repeated pulmonary
aspirations or urinary retention and urinary catheteriza-
tion. Another explanation why infections were frequent
may be that the immunological state is impaired after a
stroke, thus increasing the risk of infections in the early
phase after discharge.17 A significantly higher proportion
of patients were readmitted with infections during the
first 30 days compared to day 31-60, and it is possible
that early readmissions for infection might also relate to
delayed hospital-acquired infections or insufficiently
treated hospital infections. Alertness for subclinical infec-
tions during the hospital stay and appropriate rehabilita-
tion such as early supported discharge may reduce
readmission for infection.18
Vascular events were a frequent cause of readmission,
especially within 90 days after discharge. This has previ-
ously been reported6 and could be caused by a prothrom-
botic state in some patients in the early phase after
ischemic stroke. Atherosclerotic etiology and atrial fibril-
lation were associated with early readmission. A high risk
of early stroke recurrence has been reported for athero-
sclerotic infarctions.19 We found that patients readmitted
early had higher frequencies of complications with infec-
tion during index admission compared to patients read-
mitted late. In addition, infection is becoming well
recognized as a risk factor for cardiovascular events.
The mechanisms are thought to be a prothrombotic state
caused by atherosclerotic plaque instability, immunohe-
matological alterations, activation of platelets and proin-
flammatory cytokines, and endothelial dysfunction.20
Keeping in mind that recurrent ischemic stroke was a
common cause of early readmission, this suggests that
preventing infections could be important when aiming
to prevent readmission.
In addition to causing stroke by thromboembolic mech-
anisms, atherosclerosis may cause hemodynamic stroke.
Watershed infarctions are often caused by hemodynamic
compromise due to severe arterial stenosis.21 In our study,
patients with watershed infarctions had especially high
frequencies of readmission for recurrent ischemic stroke







Age (y) 1.02 1.00-1.03 .02
Sex 1.12 .81-1.55 .50
mRS score* 1.21 1.09-1.35 ,.01




Atrial fibrillation 1.54 1.08-2.19 .02
Abbreviation: mRS, modified Rankin Scale.
*Per mRS point.
yIschemic stroke etiology based on TOAST.







Age (y) 1.02 1.00-1.03 ,.01
Sex .79 .55-1.14 .21
mRS score * 1.11 .98-1.25 .10




Abbreviation: mRS, modified Rankin Scale.
*Per mRS point.
yIschemic stroke etiology based on TOAST.
Table 5. Factors associated with early (# 90 days) versus






Age (y) 1.00 .98-1.02 .73
Sex 1.29 .84-1.99 .25
mRS score* 1.21 1.01-1.45 .035








Atherosclerosisz 2.63 1.38-5.02 ,.01
Abbreviation: mRS, modified Rankin Scale.
*Per mRS point.
yComplication during index admission.
zIschemic stroke etiology based on TOAST.
Figure 1. Kaplan–Meier failure estimates on readmission by etiology of
index ischemic stroke (TOAST).
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within 90 days. It is likely that both hemodynamic
compromise and a prothrombotic state contribute to
high readmission frequencies for vascular events in
patients with atherosclerotic ischemic stroke. We suggest
that thorough investigation to disclose the etiology of
stroke during the hospital stay may result in better sec-
ondary preventive treatment and thereby reduce read-
mission because of recurrent stroke.
Patients with ischemic stroke due to small-vessel dis-
ease had significantly lower frequencies of both early
and late readmission (Fig 1). The low readmission risk
was also present when adjusting for physical function.
It is possible that small-vessel disease is less associated
with factors causing readmission than other etiologies
for ischemic stroke. Furthermore, small-vessel disease
does not cause cortical lesions with deficits such as
neglect, apraxia, and cognitive impairment, which might
lead to readmission.
Impaired physical function was associated with early
readmission. An association between impaired physical
function and 1-year readmission has previously been
reported.6,10 Impaired physical function is associated
with both infection and vascular events. Our study
suggests that the association between impaired physical
function and readmission is especially high in the early
period after discharge because of infection and ischemic
stroke. Adequate physical exercise after discharge might
improve this.
We found that the risk factor burden was associated
with early readmission. We have not been able to identify
any other comparable studies which have made such a
score in connection with readmission after stroke. Our
findings add new information on the importance of the
risk factor burden. Other studies have shown that the
risk factor burden is associated with mortality and
vascular events.22,23
Increased length of index admission for stroke may be
associated with readmission.6,8,9 We found, however, no
difference in length of index admission between the
readmitted and not readmitted patients. Furthermore,
the median length of index admission in our population
was substantially lower than previously reported by
other studies7,8 and comparable to only 2 other studies
which both reported length of index admission to be
associated with readmission.6,9 However, comparing
early and late readmission showed that patients who
were readmitted early had shorter length of index
admission than patients readmitted late, even when
adjusting for confounding factors including physical
function and infection during index admission. This
may indicate that some patients with stroke-related infec-
tions were discharged too early.
To our knowledge, this is the first study comparing
patients readmitted within different time intervals during
the first year after ischemic stroke. A weakness of our
study is that there is no assessment of treatments the
patients may have received after discharge or of compli-
ance. All information and subjects are collected from a
single hospital, and caution is needed when generalizing
our findings. Furthermore, a few patients may have been
readmitted to other hospitals although our hospital is
responsible for all unplanned readmissions of the patients
in this study.
In conclusion, readmission is frequent, especially in the
early period after hospital discharge. Diagnoses and
predictors varied according to time point for readmission,
reflecting different underlying mechanisms for causes
of readmission. Causes of early readmission may
include a prothrombotic state and disposition for recur-
rent infections.
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One-year versus five-year hospital
readmission after ischemic stroke and TIA
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Abstract
Background: The burden of hospital readmission after stroke is substantial, but little knowledge exists on factors
associated with long-term readmission after stroke. In a cohort comprising patients with ischemic stroke and
transient ischemic attack (TIA), we examined and compared factors associated with readmission within 1 year and
first readmission during year 2–5.
Methods: Patients with ischemic stroke or TIA who were discharged alive between July 2007 and October 2012,
were followed for 5 years by review of medical charts. The timing and primary cause of the first unplanned
readmission were registered. Cox regression was used to identify independent risk factors for readmission within 1
year and first readmission during year 2–5 after discharge.
Results: The cohort included 1453 patients, of whom 568 (39.1%) were readmitted within 1 year. Of the 830 patients that
were alive and without readmission 1 year after discharge, 439 (52.9%) were readmitted within 5 years. Patients readmitted
within 1 year were older, had more severe strokes, poorer functional outcome, and a higher occurrence of complications
during index admission than patients readmitted during year 2–5. Cardiovascular comorbidity and secondary preventive
treatment did not differ between the two groups of readmitted patients. Higher age, poorer functional outcome, coronary
artery disease and hypertension were independently associated with readmission within both 1 year and during year 2–5.
Peripheral artery disease was independently associated with readmission within 1 year, and atrial fibrillation was associated
with readmission during year 2–5.
Conclusions: More than half of all patients who survived the first year after stroke without any readmissions
were readmitted within 5 years. Patients readmitted within 1 year and between years 2–5 shared many risk
factors for readmission, but they differed in age, functional outcome and occurrence of complications during
the index admission.
Keywords: Hospital readmission, Ischemic stroke, TIA, Risk factors, Epidemiology, Outcome
Background
Stroke survivors carry a high risk of new diseases due to
functional disability, neurological deficits and pre-existing
cardiovascular risk factors and comorbidity [1]. Readmis-
sions after stroke are frequent, particularly during the first
3 months after stroke when more than half of all patients
readmitted within 1 year presents [2–4]. The neurological
and functional impairments often improve during the first
year after stroke, but the number of readmitted patients
steadily increases in the chronic phase, and between 67
and 83% of all stroke patients have been readmitted within
5 years [4–6]. Despite this, less is known about the
long-term risk of readmission for stroke patients who sur-
vive the early phase after stroke without any readmissions.
Several studies have examined predictors for readmission
after stroke. Data on causes of readmissions after stroke
can be used to prevent future avoidable readmissions. Al-
though the study findings are inconsistent, factors associ-
ated with 1-year readmission include older age [2, 7–10], a
history of stroke [2], diabetes mellitus, [11] coronary artery
disease [2], in-hospital complications [2, 10], longer length
of hospital stay [2, 7, 11], and poor functional outcome [2,
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11]. Predictors of readmission in the chronic phase of
stroke after 1 year have not been identified. Furthermore, it
is possible that patients readmitted within the first year dif-
fer from patients that experience the first readmission later,
as the early readmission may to a higher extent be directly
related to acute post-stroke complications and the
post-acute stroke treatment, and patients readmitted within
the first year may be more severely impaired than patients
readmitted later.
The aims of our study were to identify 1) predictors of
readmission within 1 year, 2) predictors of first readmis-
sion during year 2–5, and 3) factors differing between
patients readmitted within 1 year and patients with the
first readmission during year 2–5 after ischemic stroke
and transient ischemic attack (TIA). We hypothesized
that patients readmitted within the first year are more
affected by acute complications during the index admis-
sion, have more severe strokes and poorer functional
outcome than patients readmitted later, and that trad-
itional cardiovascular risk factors are more prominent in
patients readmitted within the first year after stroke.
Methods
All patients > 18 years of age admitted to the Stroke Unit
at the Department of Neurology with ischemic stroke or
TIA, Haukeland University Hospital from July 1, 2007 to
September 31, 2012, were prospectively registered in the
Bergen NORSTROKE Registry. The Stroke Unit serves a
well-defined geographical area with approximately
275,000 inhabitants. For the present study, we excluded all
patients with residence outside the hospital catchment
area due to difficulties of long-term follow-up. We also ex-
cluded patients who died during the index admission and
patients who were discharged to palliative care.
Ischemic stroke was defined as an episode of neuro-
logic deficit lasting > 24 h or clinical symptoms of TIA
where computed tomography or magnetic resonance im-
aging showed acute infarctions related to the initial
symptoms [12]. TIA was diagnosed clinically and was
defined as transient focal cerebral dysfunction < 24 h
with no objective evidence of acute brain infarction on
imaging. Duplex ultrasound of the carotid arteries, echo-
cardiogram, Holter monitoring, echocardiography and
serology were obtained during hospital admission.
Stroke etiology was classified by an experienced stroke
neurologist (HN) according to the Trial of Org 10,172 in
Acute Stroke Treatment (TOAST) criteria [13]. Stroke
severity was determined by the National Institutes of
Health Stroke Scale (NIHSS) score on admission and
day 7, or at discharge if earlier. Short-term functional
outcome was determined by modified Rankin Scale
(mRS) and Barthel Index on day 7 or at discharge if earl-
ier. Clinical characteristics, treatment, comorbidity, med-
ical history, in-hospital complications and discharge
destination were registered. Secondary prevention was
based on the Norwegian guidelines for stroke treat-
ment [14].
Information on readmission and death within 5 years
after discharge was collected by review of the medical
records from all nine hospitals in the region of the
Western Norway Regional Health Authorities. Readmis-
sion was defined as the first unplanned admission for
any cause to any hospital department after the index ad-
mission. The timing and primary cause of the first re-
admission were registered, and readmitted patients were
divided into two groups: first readmission within 1 year
after discharge, and first readmission within year 2–5.
Causes of readmission were categorized as recurrent
stroke, stroke-related event (including neurological de-
terioration, hemorrhagic transformation of cerebral in-
farction, neurological complications after carotid
endarterectomy, and suspected stroke or TIA with no
specific final diagnosis), seizure, cardiac disease, infec-
tion, fracture, gastrointestinal hemorrhage, venous
thromboembolism, and other cause. Hemorrhagic trans-
formation was defined as petechial or confluent
hemorrhage in the same area as the primary infarction.
The study was approved by the Regional Ethics Com-
mittee for Medical and Health Research Ethics in West-
ern Norway (REC West). Written informed consent was
obtained from all patients. In cases where patients suf-
fered severe strokes and were not able to give informed
consent, this was obtained from their legally authorized
representatives as required by the Regional Ethics Com-
mittee for Medical and Health Research Ethics in West-
ern Norway.
Statistics
Baseline characteristics were examined by using the χ2
test for categorical variables and Student’s t-test or
Mann-Whitney’s U-test for the continuous variables as
appropriate. A Kaplan-Meier failure curve was made to
demonstrate the incidence of readmission over time, and
the log-rank test was used to compare the incidence of
readmission between ischemic stroke and TIA. Cox re-
gression analyses were used to examine factors associ-
ated with readmission within 1 year and first
readmission during year 2–5 after discharge with back-
ward selection method. Patients who were readmitted or
dead within 1 year after discharge were excluded from
the analyses on readmission from year 2–5. Patients who
died or moved outside the area of the Western Norway
Regional Health Authorities before the end of follow-up
without any readmission were censored in the
Kaplan-Meier analysis and the Cox regression models.
All multivariate analyses were performed with stepwise
backward elimination starting with all significant param-
eters from the univariate analyses (P < .05). Age, sex and
Bjerkreim et al. BMC Neurology           (2019) 19:15 Page 2 of 8
mRS score were forced into each analysis to adjust for
potential confounding. Statistical analyses were per-
formed using Stata 14.0 (Stata Corporation, College Sta-
tion, TX, USA).
Results
The study cohort included 1453 patients discharged alive
from our stroke unit, of whom 1303 (89.7%) were diag-
nosed with ischemic stroke and 150 (10.3%) were diag-
nosed with TIA. Baseline characteristics of the study
cohort are shown in Table 1.
Within 1 year after discharge from the index admis-
sion, 568 (39.1%) patients were readmitted and 163
(11.2%) patients were dead, of whom 108 (66.3%) had
been readmitted at least once. Of the 830 patients that
were alive and free of readmission 1 year after discharge,
439 (52.9%) were readmitted within 5 years. Figure 1
demonstrates the incidence estimates of readmission
over time. There were no differences in the 5-year inci-
dence of readmission between ischemic stroke and TIA.
After 5 years, a total of 1007 patients (69.3%) had been
readmitted, and 358 patients (24.6%) were alive and
without any readmission. A total of 492 patients (33.9%)
were dead wihtin 5 years after discharge, of whom 280
(56.9%) had been readmitted within 1 year and 124
(25.2%) had the first readmission during year 2–5.
Baseline characteristics of patients readmitted within
1 year and patients with the first readmission between
year 2–5 are shown in Table 2. On univariate analysis,
patients readmitted within 1 year were older, had a
poorer short-term functional outcome, a higher dis-
charge NIHSS score, and more complications during
index admission than patients with the first readmission
between year 2–5. A stroke subtype of small vessel oc-
clusion was more frequent in patients with the first re-
admission between year 2–5. Cardiovascular risk factors
and comorbidity did not differ between the two groups
of readmitted patients, and neither did prescribed sec-
ondary preventive treatment at discharge or at the time
of the first readmission. A higher percentage of patients
readmitted within the first year had stopped smoking be-
fore the index admission, whereas more patients had
quit smoking after the index admission in patients that
were readmitted between years 2–5. Of the patients that
were smoking at the time of the index stroke, 37% of the
patients readmitted between year 2–5 had stopped
smoking compared to 28% of patients readmitted during
the first year (p = 0.144). Patients readmitted within 1
year were more often discharged to nursing homes and
less often discharged home without help than patients
readmitted between year 2–5.
Increasing age, poorer short-term functional outcome
(increasing mRS score), and a history of peripheral
artery disease, coronary artery disease, or hypertension,
independently increased the risk of readmission within
1 year after discharge, whereas a stroke subtype of small
vessel occlusion significantly decreased the risk of
Table 1 Baseline characteristics of the study cohort
Characteristics Values
Age (years), mean ± SD 73.1 ± 13.7
Male sex, N (%) 782 (53.8)
NIHSS score at discharge, median (IQR) 1 (0, 4)
mRS score at discharge, median (IQR) 2 (1, 3)
Barthel Index at discharge, median (IQR) 100 (70, 100)
Stroke subtype, N (%)
Large-artery atherosclerosis 193 (13.3)
Cardioembolism 473 (32.6)
Small vessel occlusion 159 (10.9)
Other determined etiology 20 (1.4)
Undetermined etiology 608 (41.8)
Comorbidity, N (%)
Prior stroke 299 (20.6)
Peripheral artery disease 102 (7.0)
Coronary artery disease 325 (22.4)
Diabetes mellitus 211 (14.5)
Atrial fibrillation 428 (29.5)
Hypertension 813 (56.0)
Ever-smoker 832 (57.3)
Complications during index admission, N (%)
Pneumonia 112 (7.7)
Enteral feeding 117 (8.1)
Urinary tract infection 184 (12.7)
Urinary retention 327 (22.5)
Urinary incontinence 212 (14.6)
Seizures 35 (2.4)
Stroke in progression 130 (9.0)
Any complication 599 (41.2)
Length of stay, median (IQR) 6 (3, 11)





Discharge status, N (%)
Home without care 792 (54.6)
Home with care 164 (11.3)
Rehabilitation department 112 (7.7)
Nursing home 337 (23.2)
Other department 46 (3.2)
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readmission within 1 year (Table 3). Increasing age,
poorer short-term functional outcome, a history of cor-
onary artery disease, atrial fibrillation, or hypertension,
independently increased the risk of readmission between
year 2–5 if alive and free of readmission 1 year after dis-
charge (Table 4).
The most frequent cause of the first readmission
within 1 year was infection, followed by recurrent stroke,
stroke-related event and cardiac disease In contrast, car-
diac disease was the most frequent cause of the first re-
admission for patients readmitted during years 2–5,
followed by infection, stroke-related event and recurrent
stroke (Table 5).
Discussion
We found that 69.3% were readmitted within 5 years
after ischemic stroke or TIA, with more than half of
all readmitted patients presenting during the first
year. A smaller Norwegian study demonstrated that
56% of all readmissions within 10 years presented dur-
ing the first year after stroke and similar patterns
have been reported from the US [4–6]. In line with
previously reported 1-year readmission rates between
31 and 55%, we found that 39% were readmitted
within the first year after discharge [2, 3, 6, 15, 16].
The high rates of readmission during the first year
after stroke might reflect an increased vulnerability
for post-stroke complications such as infections, re-
current stroke and other cardiovascular events in the
early phase after stroke [1].
We also found that more than half of all patients that
survived for 1 year without any readmission were re-
admitted within 5 years. The frequency of the different
causes of readmission varied slightly depending on the
timing of the first readmission, but infection, cardiac dis-
ease, recurrent stroke and stroke-related events were the
four most common causes in both time periods. Higher
age, poor functional outcome, hypertension and coron-
ary artery disease were all independently associated with
readmission both within 1 year and during year 2–5.
This indicates that even if the patients survive the vul-
nerable early period after stroke, they still have a high
risk of readmission for the same causes as patients re-
admitted during the first year after stroke, and the same
factors might impact the risk of readmission also in the
more chronic phase after stroke.
Higher age and poorer short-term functional outcome
predicted readmission within 1 year and from year 2-5,
but patients readmitted within 1 year were older, had a
poorer short-term functional outcome and more compli-
cations during index admission than patients readmitted
later. Complications during the index stroke admission
have been associated with early readmission in several
studies, and probably relates to both high age and poor
functional outcome [17, 18]. Higher age and poor func-
tional outcome have been identified as predictors for re-
admission after stroke in several other studies [2, 7–11].
Although age is a non-modifiable risk factor for readmis-
sion, a focus on improving and maintaining physical func-
tion and mobility during the stroke hospitalization and in
the period after discharge for patients at all ages is import-
ant and could potentially help prevent some readmissions.
Hypertension and coronary artery disease were identi-
fied as common predictors of readmission within 1 year
and from year 2-5, and contrary to our hypothesis, the
vascular risk factor profile was not more prominent in
patients readmitted within 1 year. Hypertension and cor-
onary artery disease are important risk factors for
Fig. 1 Kaplan Meier failure curves showing incidence estimates of readmission within 5 years for patients with ischemic stroke (n= 1303) or TIA (n= 150)
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Age (years), mean ± SD 76.2 ± 12.5 73.3 ± 13.1 < 0.001
Male sex, N (%) 298 (52.5) 242 (55.1) 0.401
NIHSS score at discharge, median (IQR) 2 (0, 5) 1 (0, 3) < 0.001
mRS score at discharge, N (%) < 0.001
0–2 323 (56.9) 304 (69.3)
3–5 245 (43.1) 135 (30.8)
Barthel Index at discharge, median (IQR) 100 (60, 100) 100 (85, 100) < 0.001
Stroke diagnosis, N (%) 0.992
Ischemic stroke 510 (89.8) 395 (90.0)
TIA 58 (10.2) 44 (10.0)
Stroke subtype, N (%) 0.070
Large-artery atherosclerosis 85 (15.0) 53 (12.1)
Cardioembolism 206 (36.3) 152 (34.6)
Small vessel occlusion 44 (7.8) 55 (12.5)
Other determined etiology 8 (1.4) 3 (0.7)
Undetermined etiology 225 (39.6) 176 (40.1)
Comorbidity, N (%)
Prior stroke 137 (24.1) 96 (21.9) 0.401
Peripheral artery disease 54 (9.5) 29 (6.6) 0.097
Coronary artery disease 162 (28.5) 103 (23.5) 0.071
Diabetes mellitus 97 (17.1) 64 (14.6) 0.283
Atrial fibrillation 197 (34.7) 135 (30.8) 0.188
Hypertension 358 (63.0) 256 (58.3) 0.128
Ever-smoker 384 (67.6) 285 (64.9) 0.371
Complications during index admission, N (%)
Pneumonia 54 (9.5) 22 (5.0) 0.007
Enteral feeding 59 (10.4) 24 (5.5) 0.005
Urinary tract infection 86 (15.1) 49 (11.2) 0.066
Urinary retention 154 (27.1) 76 (17.3) < 0.001
Urinary incontinence 107 (18.8) 47 (10.7) < 0.001
Seizures 17 (3.0) 9 (2.1) 0.350
Stroke in progression 59 (10.4) 25 (5.7) 0.008
Any complication 281 (49.5) 157 (35.8) < 0.001
Length of stay, median (IQR) 6 (3, 11) 6 (3, 10) 0.190
Discharge status, N (%) < 0.001
Home without care 257 (45.4) 255 (58.1)
Home with care 84 (14.8) 57 (13.0)
Rehabilitation department 37 (6.5) 35 (8.0)
Nursing home 162 (28.6) 83 (18.9)
Other department 26 (4.6) 9 (2.1)
Treatment at discharge, N (%)
Platelet inhibitor 379 (66.7) 302 (68.8) 0.487
Anticoagulation 203 (35.7) 148 (33.7) 0.805
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recurrent stroke and cardiac disease, which were fre-
quent causes of readmission within both 1 year and year
2-5 in our study, and are highly important causes of
death after stroke [19, 20]. Hypertension is the most im-
portant modifiable risk factor for stroke and other car-
diovascular diseases, and blood pressure reduction
reduces the risk of recurrent stroke, myocardial infarc-
tion and cardiovascular death after stroke [21]. This em-
phasizes the importance of accurate and aggressive
treatment of cardiovascular risk factors in preventing
new vascular events and vascular mortality after ische-
mic stroke and TIA.
Even though cardiovascular risk factors did not differ
significantly between patients readmitted within 1 year
and patients readmitted during year 2–5, recurrent stroke
and stroke-related events were more frequent causes of
readmission within 1 year, whereas cardiac disease was a
more frequent cause of readmission for patients that were
readmitted during year 2–5. We have only included the
cause of the first uplanned readmission in this study, but
studies have shown similar results in relation to recurrent
stroke and cardiac disease, with the highest incidences of
recurrent stroke observed in the early period after stroke,
and lower, yet more stable, yearly incidences of myocardial
infarction and congestive heart failure [4, 22].
Even though they differ in functional outcome, ische-
mic stroke and TIA patients did not differ in the inci-
dence of readmission. Compared to ischemic stroke
patients, both lower, similar and higher rates of readmis-
sion in TIA patients have been reported [8, 23–25]. This
could possibly be explained by differences in case mix
and use of secondary prevention and adherence to med-
ical treatment [25]. Nevertheless, TIA patients have the
same risk factor profile and underlying causes of their is-
chemic event as patients with ischemic stroke, and
should be provided accurate secondary treatment in
order to reduce subsequent vascular events and
readmissions.
Our study has some limitations. Some patients may
have been readmitted to a hospital outside the region of
the Western Norwegian Regional Health authorities,
even though this region involves a large geographical
area of Western Norway. Furthermore, we have no
information on smoking status or medical treatment re-
ceived after discharge in patients that were not
readmitted, and no information on treatment
Table 2 Distribution of baseline characteristics between patients readmitted within 1 year and patients with the first readmission






Antihypertensive drug 363 (63.9) 285 (64.9) 0.740
Statins 390 (68.7) 322 (73.4) 0.105
Treatment at readmission, N (%)
Platelet inhibitor 368 (64.8) 281 (64.0) 0.798
Anticoagulation 211 (37.2) 151 (34.4) 0.367
Antihypertensive drug 371 (65.3) 286 (65.2) 0.956
Statins 365 (64.3) 267 (60.8) 0.263
Smoking status at readmission, N (%) 0.036
Stopped smoking before index stroke 242 (66.1) 160 (58.0)
Stopped smoking after index stroke 35 (9.6) 43 (15.6)
Still smoking at readmission 89 (24.3) 73 (26.5)
Table 3 Risk factors for readmission within 1 year after ischemic
stroke or TIA
Hazard Ratio 95% Confidence Interval P
Age, years 1.02 1.01–1.03 <.001
Male sex 1.02 0.86–1.21 .835
mRS score 1.15 1.09–1.22 <.001
Small vessel occlusion 0.67 0.49–0.91 .010
Peripheral artery disease 1.42 1.06–1.89 .018
Coronary artery disease 1.29 1.07–1.57 .009
Hypertension 1.26 1.05–1.50 .012
Table 4 Risk factors for readmission between year 2-5 if alive
and without readmission 1 year after ischemic stroke or TIA
Hazard Ratio 95% Confidence Interval P
Age, years 1.03 1.02–1.04 <.001
Male sex 1.13 0.93–1.38 .217
mRS score 1.09 1.02–1.16 .014
Coronary artery disease 1.50 1.20–1.89 <.001
Atrial fibrillation 1.25 1.01–1.55 .046
Hypertension 1.38 1.13–1.68 .001
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compliance. As the study cohort originates from a single
site, the generalizability of our findings may be limited.
A strength of our study is the ascertainment of data re-
lated to the readmissions made by review of medical re-
cords, and the inclusion of a relatively large study
population investigated in a single stroke center accord-
ing to a predefined protocol with comprehensive data
collection. Although other studies have reported resem-
bling results regarding rates and causes of long-term re-
admission after stroke, our study elaborates on existing
knowledge by describing rates, causes and predictors of
readmission for patients who survive the first year after
stroke without any readmission.
Conclusions
More than half of all patients who survived the first year
after stroke without any readmission, were readmitted
within 5 years. Patients with the first readmission during
year 2–5 after discharge shared several risk factors with
patients readmitted within 1 year, but they differed in
relation to short-term functional outcome, age, and the
frequency of complications during index admission. Our
results indicate that further improvement in the effort of
reducing post-stroke complications and hospital read-
missions should continue beyond the acute phase after
stroke. More studies are needed to establish predictors
of readmission after stroke in the long-term perspective.
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